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Intestinal helminths infect over 2 billion people worldwide, and the mechanisms by 
which immunity to these pathogens is induced are not well-understood. Trichinella spiralis 
exhibits a broad geographic and host range, and is a natural pathogen of humans and rodents. 
Infection of mice and rats with T. spiralis provides a useful model of Th2 immunity in the 
mucosa. Rats exhibit a dramatic protective immune response, called rapid expulsion, in which 
90% of parasites are cleared from the intestine within one hour of challenge. We observed that 
intestinal priming and mucosal mast cell degranulation are not required for rapid expulsion to 
occur. Thus, mast cells may play a role during the induction of Th2 immunity in rats, rather than 
during the effector phase. 
The specific intestinal habitat of the parasite may influnce immunity. Although many 
parasite species are restricted in their distribution in the gastrointestinal tract, T. spiralis 
colonizes both the small and large intestines (SI and LI). The results demonstrate that mucosal 
mastocytosis and the cytokines that influence it are not prominent in the LI during worm 
expulsion, and that immunopathology is more tightly regulated in the LI than the SI. Thus, 
mechanisms of immunity and enteropathy vary in different regions of the intestine during 
helminth infection. 
The influence of innate mediators on the adaptive immune response to T. spiralis was 
also investigated. Evidence was collected suggesting that although MyD88 is influential in 
promoting Th2 responses, and there was a modest influence of the microbiota, MyD88 operates 
independently of TLRs. Mice deficient in ST2, the receptor for IL-33, recapitulated the results 
seen in MyD88-/- mice, supporting the role of IL-33 as a mediator of Th2 responses. IL-33 was 
observed in intestinal leukocytes and in epithelial cells, where it concentrated in the nucleus 
within two days of infection. Array analysis revealed that at two days after infection, targets of 
NF-κB were downregulated in the epithelium, while the TGF-β pathway was increased. IL-33 
may carry out dual functions as part of a complex mechanism of innate induction of the Th2 
response.
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1Chapter 1
Introduction1
1  Sections of this chapter were taken from: Appleton JA, Blum LK, Gebreselassie NG 
Nematoda: Trichinella. In Lamb, TJ (Ed.), Immunity to Parasitic Infections. (In press) Oxford: 
Wiley-Blackwell.
2Significance
 Intestinal helminths infect over 2 billion people worldwide, and immunity to 
these pathogens remains poorly understood (165). Secondary immunity to Trichinella spiralis 
involves a novel immune mechanism, in which the systemic antibody response is crucial 
to the expression of intestinal immunity (4). Understanding this mechanism may aid in the 
development of vaccines, which often aim to deliver antigen systemically in order to protect a 
mucosal surface. Furthermore, it has recently become clear that the absence of parasitic infection 
in many developed countries has secondary consequences, specifically by contributing to high 
rates of allergic and autoimmune diseases in these populations. This dissertation describes the 
induction and expression of intestinal immunity to different life stages of T. spiralis, in different 
regions of the host intestine, as well as the contributions of the microbiota, innate receptors, and 
the intestinal epithelium. 
Trichinella
 Trichinella is a parasitic nematode in the class Adenophorea, or Clade I by the 
molecular classification (24). It is estimated that trichinellosis has a global incidence of 10,000 
human cases per year, and it has been listed among ‘Europe’s neglected infections of poverty’ 
(35, 70). Geographically, Trichinella is widely distributed throughout the world, with different 
species occurring with higher prevalence in different host species and climates (48). The 
most widely studied species of Trichinella is T. spiralis, which is most commonly observed in 
cosmopolitan areas of Europe and Asia (48). T. spiralis infection occurs by oral ingestion of L1 
parasites that are present in the muscle tissue (meat) of the previous host. The L1 are released 
by digestion in the stomach and activated by host gut contents (such as bile) before establishing 
their initial niche in the small intestine (SI). The larvae travel rapidly within the epithelium, 
occupying a ‘multi-intracellular’ habitat near the crypt-villus junction (168, 169). They then 
molt four times to mature into adult male and female worms, which mate within the intestine. 
3Four to five days after oral infection, adult females release newborn larvae (NBL), which exit 
the intestine into the bloodstream via the mesenteric vasculature.  NBL migrate throughout the 
body, causing much of the pathology that is associated with T. spiralis infection, including liver, 
kidney, and CNS damage (48). Larvae that migrate to the skeletal muscle invade myotubes and 
establish a chronic infection. 
 Ultimately, an intestinal immune response expels the adult worms. L1 initially 
invade the duodenum and move distally over time (132). The length of time that T. spiralis adults 
remain in the intestine varies greatly among host species. Worms are cleared from the intestines 
of otherwise healthy inbred mice within a period of two to three weeks, while they can persist in 
humans and swine for more than seven weeks (10, 48, 119). 
Intestinal Immunity to T. spiralis
Primary Immunity
Clearance of adult worms from the small intestine is mediated by a potent Th2 response 
characterized by dramatic increases in the numbers of lymphocytes, eosinophils, goblet cells, 
and mucosal mast cells (10, 60, 76, 94). Blood and tissue eosinophilia are induced by interleukin 
(IL)‐5, and local T cells and monocytes recruit eosinophils to the intestine by production of the 
chemokines CCL11 (eotaxin‐1) and CCL24 (eotaxin‐2) (46, 157). Despite the prominence of 
eosinophils in the intestinal immune response, they are not required for worm clearance (50). 
Goblet cell hyperplasia during T. spiralis infection is dependent on IL‐13 (44, 84, 106). 
Goblet cells synthesize and secrete mucins, and T. spiralis worms become entrapped in mucus 
during clearance of a challenge infection, although it is unclear whether this effect is causal (30). 
The production of several goblet cell‐derived molecules is increased during infection, including 
mucin 2, mucin 3, mucin 5ac, trefoil factor 3 (TFF3), sialyl transferase 4c (Siat4c), intelectin‐2, 
and resistin‐like molecule‐β (RELM‐β) (85). Infection of gene knockout mice has shown that 
mucin 5ac is necessary for efficient expulsion of T. spiralis, while RELM‐β is not required (65, 
69). 
4Intestinal mastocytosis during infection is dependent on TNF-α, IL‐4, IL‐9, and IL‐10 
(51, 67, 72, 84, 138). Infection of mast cell‐deficient rats and mice has revealed a role for mast 
cells in worm expulsion (64, 67, 149). Furthermore, mouse mast cell protease‐1 (mMCP‐1) 
and mast cell‐derived IL-4 and TNF‐α promote worm clearance (73, 86). The impact of these 
molecules is somewhat mild compared with the profound delay in expulsion observed in T 
cell‐deficient mice, suggesting that mucosal mast cells and their mediators are part of a more 
complex mechanism (134). Evidence in support of this notion derives from the observation that 
mast cells contribute to the inductive phase of the immune response by promoting Th2 cytokine 
responses in the mesenteric lymph node (MLN) (73). 
Clearance of adult worms is severely compromised in T cell‐deficient mice, and adoptive 
transfer of lymphocytes reverses this phenotype (61, 134). The Th2 cytokines IL‐4 and IL‐13, 
which signal through a common receptor subunit (IL‐4Rα), are required for efficient expulsion 
of adult worms (138). IL‐4Rα is present on many cell types, and expulsion is delayed in mice 
in which IL‐4Rα is absent from either bone marrow‐derived or non‐bone marrow‐derived cells 
(154). Specifically, IL‐4Rα expression is not required on mast cells, CD4+ T cells, or LysM+ 
cells (macrophages and neutrophils); however, when IL‐4Rα ablation was targeted to intestinal 
epithelial cells (IECs), expulsion was delayed, supporting the conclusion that IL‐4/IL‐13 
stimulate epithelial cells to promote worm rejection (69, 112). As IL‐4Rα signaling promotes 
goblet cell hyperplasia and RELM‐β production, it is likely that stimulation of goblet cells via 
IL‐4Rα also increases Muc5ac production, thereby promoting worm clearance (69).
Protection against reinfection
The secondary immune response to T. spiralis varies among host species. Immune rats 
display a dramatic protective immunity in which 90% of intestinal larvae are cleared from the 
intestine within 30‐60 minutes and 99% of larvae are cleared within 24 hours, a phenomenon that 
has been called rapid expulsion or rapid rejection (22, 33, 99). Secondary immunity in mice is 
much less robust; immune mice exhibit expulsion of adult worms that is accelerated by 2‐7 days 
5(8, 9, 18). This immunity has not been thoroughly investigated. Secondary intestinal immunity in 
swine resembles that of mice, although swine also manifest strong immunity to NBL (102, 127). 
 In rats, tyvelose‐specific antibodies play a key role in rapid expulsion and convey as 
much as 88% protection upon suckling rats (14). In adult rats, antibody alone is not sufficient, 
and either immune T cells or infection with a heterologous intestinal parasite can enable anti-
tyvelose antibodies to effect expulsion (4, 20). Intestinal priming is not a strict requirement, 
as rats immunized with infections limited to the muscle phase produce anti‐tyvelose IgG and 
display rapid expulsion (25).
 Mucosal mast cells degranulate at the time of rapid expulsion in rats immunized with 
either oral or muscle infections, prompting speculation that mast cells are central to expulsion 
(25, 114, 166); however, recent evidence has shown that mucosal mast cell activation is neither 
sufficient nor required for rapid expulsion (Chapter 2, (25)). The mechanism that enables 
antibody‐mediated protection in adult rats remains elusive.
The action of anti‐tyvelose antibodies has been investigated in neonatal and adult 
rats, as well as in an in vitro model of epithelial cell infection. In the presence of monoclonal 
anti‐tyvelose IgG, larvae are excluded from or encumbered in the epithelium (31, 108). In vivo, 
luminal larvae become entrapped in mucus, although entrapment is reversible (19, 31). All of 
these effects are directed solely at first‐stage larvae (21). Following the first molt, larvae are no 
longer susceptible to the effects of anti‐tyvelose IgG (13).
Immunopathology
Many studies have differentiated protective from pathologic responses in the intestine 
during T. spiralis infection. T. spiralis enteropathy includes villous atrophy, crypt hyperplasia, 
edema, mastocytosis, and an increase in myeloperoxidase activity, which is associated with 
neutrophil infiltration (94-96). Furthermore, pathologic changes in smooth muscle function are 
induced by Trichinella infection, and these changes persist after worm clearance, in a syndrome 
that is referred to as post‐infectious gut dysfunction (17, 34, 103). 
6TNF‐α drives much of the enteropathy caused by Trichinella infection, promoting 
villous atrophy, crypt hyperplasia and intestinal mastocytosis (72, 73). NO also plays a role, as 
infected iNOS-deficient mice display no significant pathologic changes (95). Furthermore, Th2 
cytokines are essential for pathogenesis: IL‐4 production is required for crypt hyperplasia while 
IL‐13 mediates villous atrophy (as well as edema) (137). The cellular targets of IL‐4 and IL‐13 
include epithelial cells, but not T lymphocytes, macrophages, or neutrophils, as specific deletion 
of IL‐4Rα on the latter cells has no effect on enteropathy (112). Innate cells are important 
sources of Th2 cytokines during T. spiralis infection. In fact, mast cell production of IL‐4 (as 
well as TNF‐α and mMCP‐1) is required for enteropathy, whereas intraepithelial NK cells 
are believed to provide a potent, innate source of IL‐13 (73, 106). Indeed, non-T cell derived 
IL‐13 is sufficient to induce villous atrophy, crypt hyperplasia, and an increase in the number of 
goblet cells in immunodeficient SCID or nude (T cell deficient) mice (106); however, the recent 
discovery of type 2 innate cell populations, such as nuocytes, will prompt a reevaluation of the 
IL-13-producing cells in T. spiralis-infected immunodeficient mice. 
Figure 1.1 provides a comparison of protective and pathologic immune mechanisms 
during T. spiralis infection. 
Intestinal Habitat of the Parasite
 During intestinal colonization and expulsion, T. spiralis ultimately passes through 
every region of the rodent intestine, and these sites vary greatly with regard to morphology, 
physiology, and immunology. The intestinal epithelium represents the largest surface in the body 
of the animal, with the length alone reaching three times the height of the animal, and with a 
surface area as great as 45,000 mm2 for a rat (400 m2 for a human) (43, 83). The gastrointestinal 
tract of rats and mice is composed of the stomach, small intestine (SI), cecum, and large intestine 
(LI). Unlike humans, they do not possess an appendix. The SI is divided into three sections, 
the duodenum, jejunum, and ileum (listed in proximal to distal order). The duodenum can be 
visibly distinguished from the other two sections because it is proximal to the Ligament of Treitz. 
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8Figure 1.1: Intestinal immune response to T. spiralis. (A) Mechanisms required for primary 
clearance of adult worms. Parasites can survive for more than 80 days in the absence of Th2 
cells. Expulsion is subtly delayed in the absence of IL-4Ra on both epithelial cells and bone-
marrow derived cells. Efficient expulsion also requires the induction of mast cells via Th2 
cell-derived cytokines and mast cell production of IL-4, TNF-a, and mMCP-1. Goblet cells 
and parasite-specific antibodies also contribute to clearance. (B) Mechanisms of enteropathy 
during T. spiralis infection. (1) Villous atrophy is dependent on IL-13, NO, and mast cell 
production of IL-4, TNF-a, and mmcp-1. (2) Crypt hyperplasia is also dependent on mast 
cell products. (3) Edema is dependent on IL-13, NO, and mast cell products. (4) Leukocyte 
infiltration is induced by chemokines and Th2 cytokines. Tissue eosinophilia, driven by Th2 cell-
derived IL-5, is shown. Th2 and NK cells are the primary sources of IL-13.
9Differentiation between the jejunum and ileum is best done microscopically. The villi of the 
jejunum are taller than those of the ileum, and the ileum has a greater number of paneth cells 
(41). The crypt-to-villus ratio in the proximal duodenum is 14, while the ratio in the ileum is 6 
(170). The large intestine does not contain villi, but rather a hexagonal-shaped cuff of surface 
epithelial cells that surrounds the opening of each crypt (gland) (139). The ileum also has a 
greater number of goblet cells than the duodenum or jejunum (41). The greatest proportion of 
goblet cells is found in the LI, although this site does not contain paneth cells under normal 
conditions (41). 
Regional differences in gene regulation exist between the jejunum and ileum. The 
transcription factors Gata4 and Hnf1α are highly expressed in the jejunum but not the ileum 
(26, 27). Genes that define the phenotype of the duodenum are regulated by Pdx-1 (40, 63). The 
results of differential expression of these transcription factors along the cranial-caudal axis of the 
intestine are that enterocyte genes that are responsible for digestion and absorption of nutrients 
are most highly expressed in the duodenum and jejunum, while those that mediate absorption of 
bile salts and intrinsic factor-bound B12 are expressed in the ileum (26, 27, 40). 
 In addition to physiological and architectural differences among different regions 
of the intestine, the structural features of associated lymphoid tissues and the regulation of 
immunity varies by site. Peyer’s patches are present in the SI, with the greatest number occurring 
in the ileum, while smaller cryptopatches (also called colonic lymphoid follicles) are present 
in the LI (123). Lymphatic drainage is regional, and the chain of MLN drains all sections of 
the intestine. However, lymphocytes are differentially recruited to the SI and LI, based on 
addressin and chemokine expression in each site. While MAdCAM-1 is displayed by endothelia 
throughout the intestine and recruits lymphocytes to all compartments, CCL25/TECK is mainly 
produced in the SI where it attracts CCR9+ lymphocytes (59). Priming in the presence of retinoic 
acid (RA) directs activated T cells to traffic to the SI (by inducing α4β7 and CCR9 expression) 
(77, 107). Although migration to the large intestine also depends on α4β7, RA is neither 
necessary nor sufficient to promote homing to the LI (115). 
10
Evidence derived from a variety of disease conditions confirms that the SI and LI 
constitute distinct immune environments.  Reports describe variation in regulatory T cell 
phenotypes and in the production of IL-10 and TGF-β (15, 105). Specifically, Foxp3+IL-10+ T 
cells play a predominant role in controlling inflammation in the SI, while Foxp3-IL-10+ T cells 
are of primary importance in regulating LI inflammation (105). NADPH oxidase 1 (NOX1), 
which catalyzes the production of reactive oxygen species, is preferentially expressed in the LI 
where it is modulated by IL-10 (80, 131). Furthermore, the epithelial-derived Th2 cytokine TSLP 
is more highly expressed in the proximal LI than in the cecum or distal SI (150). The expression 
of individual toll-like receptors (TLRs) also differs between the SI and LI (reviewed in (1)). For 
example, TLR5 is expressed on the basolateral surface of IECs in the ileum and colon, but on the 
apical surface in the follicle-associated epithelium of the SI (37, 55, 130).  Contrasts in immune 
function are evident in two different inflammatory bowel diseases (IBD) in humans. Ulcerative 
colitis is a Th2-mediated disease of the LI (75). Conversely, a mixed Th1/Th17 response has 
been implicated in the etiology of Crohn’s disease, which mainly affects the distal ileum of the SI 
(54, 125). It is unclear how differences in the affected intestinal sites contribute to differences in 
the induction and manifestation of each disease. Figure 1.2 illustrates relevant differences among 
the regions of the rodent intestinal tract. 
PAMPs and DAMPs
 One of the major tenets of immunology is the differentiation between ‘self’ and 
‘non-self’, which can be modernized as differentiation between ‘non-danger’ and ‘danger’. 
Charles Janeway proposed that conserved molecular patterns alert the immune system to 
the presence of a non-self pathogen (78). These molecules were termed pathogen-associated 
molecular patterns (PAMPs), and the Nobel Prize was recently awarded to Bruce Buetler and 
Jules Hoffman for their elucidation of the identity and interaction between the bacterial PAMP 
lipopolysaccharide (LPS) and its immune receptor, TLR4. Further studies have identified 
12 mouse and 10 human TLRs, which sense ligands ranging from viral RNA to profilin in 
11
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Toxoplasma gondii (reviewed in (81)). Intracellular pathogens are also sensed by nod-like 
receptors (NLRs) and rig-like receptors (RLRs) (reviewed in (98, 141)). In the intestine, 
dendritic cells (DCs) with high and low TLR expression are both present, but neither population 
responds strongly to activation by the microbiota under normal conditions (36, 113). The 
mechanisms that induce and maintain this tolerogenic phenotype are not well understood. IECs 
in the villous epithelium of the SI do not highly express TLR5, and IECs in the LI express TLR5 
only on the basolateral surface of the cell, limiting activation to situations where the epithelium 
has been disrupted, or the microbiota have translocated across the epithelium (55). TLR3, 7, 8, 
and 9 are intracellular, and IECs do not express high levels of TLR2 or TLR4 under homeostatic 
conditions (2, 109, 110). 
In addition to sensing exogenous threats (pathogens), dangerous states within the host are 
sensed by the detection of so-called danger associated molecular patterns (DAMPs). DAMPs are 
much less well understood than PAMPs, but this is an area of active research. At this time, the 
DAMP superfamily includes debris produced from the extracellular matrix, such as hyaluronan 
fragments, heat shock proteins, S100 family proteins, uric acid, IL-1α, IL-33, and the canonical 
DAMP, high mobility group box protein 1 (HMGB1) (49, 52, 89, 118, 124, 151, 155, 156, 
164). HMGB1 is a nuclear-associated protein that is released (bound to DNA or nucleosomes) 
by necrotic cells and activates Th1 inflammation via the receptor for advanced glycation end 
products (RAGE), TLR2, and TLR4 (124, 171). DAMPs, which are also referred to as ‘alarmins’ 
or ‘endokines’, are involved in the pathology associated with sterile inflammatory conditions 
such as myocardial infarction and gout, but their role in infectious diseases where a pathogen 
causes tissue necrosis is not well known (reviewed in (144)).
Induction and Amplification of Th2 Immunity
 Despite the prodigious increase in the past 20 years in our understanding of 
how Th1 responses are induced, the innate mediators responsible for Th2 responses remain 
poorly defined. Although there appear to be context-dependent differences in the mechanisms 
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of protective immunity between T. spiralis and S. mansoni or T. muris, observations from these 
related helminths may provide insight into the potential pathways of activation during T. spiralis 
infection. DCs play a critical role in driving the direction of an immune response; when DCs are 
highly activated by bacterial or viral stimuli, they drive a strong Th1 cell response. Th2-inducing 
DCs are considered to be in a lower state of activation (100). Currently, the major innate 
pathways that are known to promote a Th2 response are TLRs, C-type lectin receptors (CLRs), 
notch signaling, and protease activation of basophils. Newly identified innate cell populations 
also initiate Th2 immunity.
Among the helminths, several molecules have been identified that influence DC 
activation. Soluble egg antigen (SEA) from S. mansoni contains lacto-N-fucopentaose III that 
activates MAPK signaling via TLR4, while schistosome lysophosphotidylserine (lyso-PS) 
induces a Th2 phenotype via TLR2 (152, 158). The protein ES-62 from the filarial nematode 
Acanthocheilonema vitae can bind to TLR4 in a manner that leads to the suppression, rather than 
induction, of IL-12 production (57, 58). However, TLR activation suppresses the Th2 response 
during T. muris infection, as Th2 immunity is diminished in MyD88-/- and TLR4 mutant C3H/
HeJ mice (68). The role of TLRs and MyD88 signaling during T. spiralis infection has not been 
reported previously.
Helminths are known to produce and secrete large quantities of immunogenic 
glycoproteins (reviewed in (159)). These motifs can be recognized by the calcium-dependent 
carbohydrate binding protein family of receptors called C-type lectin receptors (CLRs). This 
family includes DC-SIGN (human CD209) and its murine homologs, as well as intelectins and 
the mannose receptor family. These receptors bind to carbohydrate moieties and contribute to 
Th2 immunity, although their mechanism of action requires further study. S. mansoni products 
bind to the mannose receptor on macrophages (97); glycan microarray profiling in humans 
showed that macrophage galactose-type lectin (MGL, CD301) on DCs bound to specific glycan 
moieties found in S. mansoni eggs, and human DC-SIGN binds to whole S. mansoni cercariae 
(111, 160, 161). Once bound, glycan-lectin complexes are internalized, and activation of TLRs 
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is suppressed (160). The impact of these binding events in the context of infection is less clear. 
For example, although S. mansoni products activated the murine DC-SIGN homolog SIGNR1 
in vitro, SIGNR1-deficient mice did not have an altered immune response (136). In addition, T. 
muris ES products bound to the mannose receptor (MR, CD206) on macrophages, and binding 
induced cytokine production, but MR-/- mice had normal clearance of the parasite (45). It has 
been proposed that carbohydrate binding to host CLRs is a mechanism of immune suppression 
by helminths, rather than activation (159). Mannan-binding lectin (MBL) does bind to T. spiralis 
muscle larvae in vivo, although the downstream effects of MBL binding are not clear (62). 
Notch signaling is an evolutionarily conserved pathway for cell-to-cell communication 
that is important in many types of cell fate determination. Notch receptors are present on many 
cells of the immune system, including DCs, lymphocytes, and macrophages (3, 101, 121). 
Vertebrates have four notch receptors (Notch1-4), which can be bound by five different ligands 
(Delta-1, -3, and -4 and Jagged-1 and -2)(28). Stimulation of T cells or antigen presenting cells 
(APCs) in the presence of the delta ligands induces a Th1 phenotype, while stimulation in the 
presence of the jagged ligands induces a Th2 phenotype (12, 101). LPS induces the expression 
of delta family ligands in a MyD88-dependent manner, while Th2 stimuli such as PGE2 induce 
a rapid increase in the expression of the jagged family (12). Mice in which notch signaling was 
conditionally inactivated in T cells developed a non-protective Th1 response during T. muris 
infection (153). It is believed that notch signaling contributes to Th2 differentiation in response 
to SEA, although contradictory results have been reported regarding the requirement for 
individual jagged ligands (56, 90, 167). It is likely that jagged1 and jagged2 play redundant roles 
during S. mansoni infection, and that knockout of both molecules is required for a deficiency 
in Th2 induction. Interestingly, IL-33 decreases the expression of both delta and jagged ligands 
during experimentally induced dextran sodium sulfate (DSS) colitis (74).
It was recently reported that microRNAs play a role in the induction of intestinal Th2 
responses. During T. muris infection, IL-13 induces miR-375, which regulates the expression of 
TSLP, an epithelial-derived cytokine that amplifies Th2 responses (23). TSLP can potentiate the 
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response of basophils, a cell type known to promote induction of Th2 responses (143). Basophils 
respond to protease allergens, such as papain, by upregulating MHC II expression and migrating 
to the draining lymph node, where they provide an early source of IL-4 (146, 147). Exposure to 
schistosome eggs elicits a robust recruitment of MHC II+ basophils to the draining lymph node, 
and depletion of basophils impairs Th2 cytokine-mediated expulsion of T. muris (126). Basophils 
are also increased by up to 10-fold in the MLN and spleens of mice infected with T. spiralis 
(Gebreselassie and Appleton, in preparation).
Previously unrecognized innate cell populations have recently been described as 
crucial to the initiation of Th2 responses. It is unclear whether natural helper cells, nuocytes, 
multi-potent progenitor type 2 (MPPtype2) cells, and innate helper 2 (Ih2) cells, which were 
independently reported by four research groups, are the same or distinct populations (117, 120, 
128, 135). These cells are induced by the tissue-derived cytokines IL-25 and IL-33 to potentiate 
the Th2 cytokine response, particularly IL-5 and IL-13 (117, 120, 128, 135). In addition, they 
share a surface phenotype that is negative for lineage markers (T, B, NK, macrophage, DC, 
neutrophil, and LTi markers), negative for FcεRI, CCR3, and CD49b, yet positive for c-kit (117, 
120, 128, 135). MPPtype2 cells are preferentially activated by IL-25 and do not express ST2, the 
receptor for IL-33, while the other three populations can respond to both IL-25 and IL-33 (117, 
120, 128, 135). MPPtype2 cells, nuocytes, and Ih2 cells have all been documented to be active in 
Th2 immunity during helminth infections (117, 120, 128, 135).
Interleukin-33
 IL-33 (IL-1F11) is an IL-1 family cytokine that contains the classic β trefoil 
structure found in this family (140). It was identified as the ligand for the orphan-receptor ST2, 
and was originally called nuclear factor of high endothelial venules (NF-HEV) (16, 140). IL-
33 is predominantly expressed in cells that are exposed to the external environment, such as 
the skin, intestine, and lung, but it is also present at crucial sites in the body such as the brain, 
heart, and airway smooth muscle (118). In addition, IL-33 mRNA is expressed by activated mast 
16
cells, DCs, and macrophages (122). Although it was originally described as being processed by 
caspase-1 into a cleaved active form, subsequent studies have shown that full-length (30 kDa) 
IL-33 is biologically active (7). Furthermore, it is cleaved by caspase-3 and -7 during apoptosis, 
which leads to inactivation of the ST2-dependent functions of IL-33 (7). It is believed that IL-33 
is released in its active form by necrotic cells and is inactivated during apoptosis. 
The paracrine effects of IL-33 are mediated via its receptor, ST2, which is expressed on 
a wide variety of leukocytes, including mast cells, basophils, eosinophils, neutrophils, Th2 cells, 
NK cells, alternatively activated macrophages, and nuocytes/natural helper cells (42, 93, 116, 
128, 129, 140, 145). The receptor complex includes ST2 and the IL-1 receptor accessory protein, 
IL-1RAcP (38). Binding of IL-33 to ST2 leads to activation of NF-κB via MyD88, IRAK-1, and 
TRAF6 (5, 53, 91, 140). In mast cells, IL-33 receptor signaling also synergizes with activation of 
c-kit, and to a lesser extent FcεRI to amplify cytokine production and degranulation, respectively 
(47, 142). The ST2-IL-33 axis is regulated by a soluble alternative splice variant of ST2, sST2, 
which blocks activation of the functional receptor (66). Intracellularly, single Ig IL-1R-related 
molecule (SIGIRR) acts as a negative regulator of ST2 signaling (29).
 IL-33 demonstrates biological functions in the mucosa that include an increase 
in Th2 cytokine expression, goblet cell hyperplasia, airway hyper-responsiveness, neutrophil 
and Th2 cell migration, and activation of eosinophils (11, 71, 82, 87, 88, 140, 148, 163). IL-33 
is highly expressed in the intestines of patients with UC, and it was found to be crucial in the 
Samp1/YitFc mouse model of IBD. Expression of IL-33 was increased at a single early time 
point (day 3) of T. muris infection, and injection of recombinant IL-33 promoted intestinal 
parasite clearance (71). In addition to its role in Th2 immunity, IL-33 is also influential in 
Toxoplasma encephalitis, inflammatory hypernociception, and Influenza virus infection (39, 
79, 162). More work is needed to determine the precise mechanisms by which ST2 induces the 
amplification of immune responses under different conditions, such as Th1 or Th2 inflammation, 
as well as whether IL-33 influences Th17-mediated immunity. 
 In addition to its role as a paracrine cytokine, IL-33 also carries out an 
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intracellular signaling mechanism, which is not fully understood (32). In the endothelia of 
certain tissues, IL-33 is constitutively located in the nucleus, where it binds to the histone H2A/
H2B acidic pocket, and is released in response to inflammatory stimuli (92, 133). Although the 
function of this shift has not been extensively studied, nuclear translocation was associated with 
reduced expression of a Gal4 reporter gene, and was proposed as a mechanism for controlling 
proliferation in pancreatic stellate cells (32, 104). Many of the studies regarding IL-33 nuclear 
translocation have been carried out in transfected cell lines, which may not be an accurate model 
of the natural functions of nuclear IL-33. It was recently reported that nuclear IL-33 binds to 
NF-κB and prevents it from acting as a transcriptional activator, but the significance of NF-κB 
inhibition by IL-33 has not yet been investigated in vivo (6). Further work is needed to dissect 
the pleiotropic functions of IL-33 during intestinal helminth infection. 
Synthesis
The results presented in this dissertation describe the role of mast cells in protective 
secondary immunity, differences in protection and pathology among different regions of the 
intestine, and the contribution of innate mediators in initiating the Th2 response to infection. 
Primary infection with T. spiralis induces many cellular and physical changes in the rodent 
intestine. Some of these changes contribute to protective immunity, while others are merely 
pathologic. The study reported in Chapter 2 shows that although mucosal mast cells dramatically 
increase in number during natural infection of rats, mastocytosis and mucosal mast cell 
degranulation are not required for protective immunity. We also report that the mechanisms 
of primary immunity may differ among different regions of the intestine, and that pathology 
induced by infection is regulated differently in the different sites (Chapter 3). These results fit 
well with known differences in the immune milieus between the SI and LI; in particular, cytokine 
production during infection was parallel between the jejunum and ileum (but not the LI), which 
fits with the specific re-circulation of CCR9+ leukocytes within the SI. The mechanisms by 
which Th2 immune responses are induced in the intestine are not fully understood. However, it 
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is known that T. spiralis causes physical disruption of the intestinal epithelium during infection. 
The results presented in Chapter 4 illustrate dramatic changes that occur in the intestinal 
epithelium during infection, and the mechanisms by which those changes promote a robust Th2 
response. 
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CHAPTER 2
Expulsion of secondary Trichinella spiralis infection in rats occurs 
independently of mucosal mast cell release of mast cell protease II1
1  Originally published in The Journal of Immunology. 
Blum L.K., Thrasher S.M., et al. 2009. J. Immunol. 183 (9): 5816-22. Copyright © [2009] The 
American Association of Immunologists, Inc.
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Abstract
Our aim was to elucidate the contribution of mucosal mast cells to the effector phase of 
a secondary immune response to Trichinella spiralis. During secondary infection, rats expel 90 
to 99% of T. spiralis L1 from the intestine in a matter of hours.  This phenomenon appears to 
be unique to rats and has been called rapid expulsion. Primary intestinal infection by T. spiralis 
induces mastocytosis and mast cell degranulation occurs when challenged rats exhibit rapid 
expulsion. These observations have engendered the view that mast cells mediate rapid expulsion. 
Here we report that. immunization of adult AO rats by an infection limited to the muscle phase 
did not induce intestinal mastocytosis, yet such rats exhibited rapid expulsion when challenged 
orally. Although mastocytosis was absent, the protease unique to mucosal mast cells, rat mast cell 
protease II (RMCPII), was detected in sera at the time of expulsion. We further evaluated mast 
cell activity in neonatal rats that display rapid expulsion. Pups born to infected dams displayed 
rapid expulsion and RMCPII was detected in their sera. By feeding pups parasite-specific 
monoclonal or polyclonal antibodies before challenge infection, it was possible to dissociate 
mast cell degranulation from parasite expulsion. These results indicate that rapid expulsion can 
occur in the absence of either intestinal mastocytosis or RMCPII release.  Furthermore, release 
of RMCPII is not sufficient to cause expulsion. The data argue against a role for mast cells in the 
mechanism underlying the effector phase of protective immunity against T. spiralis in rats.
Introduction
 Rodents are natural hosts for Trichinella spiralis, a parasitic nematode that 
colonizes the epithelium of the small intestine. In both mice and rats, primary infection induces 
a potent Th2 response leading to intestinal mastocytosis (1).  Mast cell degranulation can 
be detected at the time of adult worm expulsion (2-4). The temporal alignment of intestinal 
mastocytosis and mast cell degranulation with the rejection of adult worms provided evidence 
that mast cells may be key to intestinal defense against the parasite. Support for this notion 
has been provided by reports that rejection of both primary and secondary intestinal infections 
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with T. spiralis is delayed in mast cell deficient W/Wv mice (5, 6) and that the capacity to reject 
adult worms can be reconstituted with bone marrow cells (7). Studies with wild type and IL-9 
transgenic mice treated with anti-c-kit antibodies confirmed these results (8, 9). Furthermore, 
mice deficient in mast cell protease-1 (mMCP-1) show delayed rejection of T. spiralis (10). It has 
been hypothesized that mMCP-1 increases intestinal permeability, providing antibodies access to 
parasite antigens (11); however, the mechanism of adult worm rejection remains unproven. 
Rats respond to a secondary T. spiralis infection with a dramatic and immediate immune 
response. This rapid expulsion of first-stage larvae (L1) has been likened to intestinal anaphylaxis 
(12-14). Mice do not exhibit rapid expulsion, although they do reject secondary intestinal 
infections in an accelerated fashion (15, 16).   Mast cell degranulation is coincident with rapid 
expulsion in rats, as revealed by detection of rat mast cell protease II (RMCPII) in the serum 
(2); however, there is no direct evidence that mast cells contribute to expulsion. Mast cells have 
been reported to be the sole cellular source of RMCPII in intestinal tissue of naïve rats (17, 18). 
RMCPII-positive cells are present in the lung, liver and primary lymphoid tissue (19); however, 
intestinal mast cells are very likely to be the major source of blood RMCPII, when antigenic 
challenge is limited to the intestine.
The participation of antibodies in rapid expulsion of T. spiralis has been documented 
in passively immunized rat pups. Immune serum or parasite-specific monoclonal IgG1 or 
IgG2c confer an immunity on pups that is indistinguishable from rapid expulsion displayed by 
previously infected adult rats (20, 21). Protective antibodies are specific for tyvelose-bearing 
glycans that are unique to L1 (22).  In the presence of tyvelose-specific antibodies, L1 are 
excluded from the epithelium, entrapped in mucus, or encumbered in epithelial cells (23, 24).  
Antibodies are protective when delivered to pups orally or by intra-peritoneal injection, or when 
passively transferred in milk from the mother (20, 21). Passive immunization is not effective in 
rats after weaning (25). The two rat isotypes known to activate mast cells, IgE and IgG2a, do not 
protect neonates (21, 26).
In contrast to rat pups, passive immunization of adult rats is effective only after intestinal 
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priming. Infection with either Nippostrongylus brasiliensis (27, 28) or Heligmosomoides 
polygyrus (27) enables passively transferred serum antibodies or monoclonal anti-tyvelose 
antibodies to confer immunity. Infection with either of these parasites induces mastocytosis as 
well as many other innate cellular changes in the small intestine.  In the studies described here, 
we sought to investigate the requirement for intestinal priming using an immunization scheme 
that did not involve intestinal infection.  In addition, we investigated the activity of mast cells 
in passively immunized rat pups, as pups do not require intestinal priming for immunity.  Our 
findings indicate that rapid expulsion occurs in the absence of mastocytosis and that mast cell 
release of RMCPII is neither required nor sufficient for immunity.
Materials and Methods
Rats
Albino Oxford (AO) and PVG strain rats were produced and maintained under specific-
pathogen-free conditions in the James A. Baker Institute vivarium according to the guidelines of 
the American Association for Accreditation of Laboratory Animal Care.  
Outbred, male NIH-RNU (athymic) and heterozygous NIH-RNU/+ rats (02N01 Cr:NIH-
rnu) were obtained from NCI-Frederick and were barrier maintained. Rats were euthanized by 
CO2 inhalation and cervical dislocation.  Blood samples were collected from the tails of rats 
under anesthesia with isoflurane, or from the heart post-mortem. 
Parasite
Trichinella spiralis (pig strain) was maintained in irradiated adult AO rats as described 
by Crum et al. (29). Infectious L1 were harvested from muscle by digestion in a solution of 1% 
pepsin-1% HCl at 37°C. Newborn larvae (NBL) were recovered from cultures of adult worms as 
described by Beiting et al. (30). Adult rats, 8 to 12 weeks old, were immunized by oral infection 
with 1000 L1 or by infection limited to muscle by injection of 80,000 NBL in the lateral tail vein. 
Adult rats were challenged 9 weeks after the immunizing infection. The challenge dose was 
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500 L1 for adult rat experiments. Pups (12 to 16 days old) were challenged with 200 L1.  Small 
intestines were collected for parasite enumeration 18 to 24 hours post-challenge for adult rats, 
and 3 hours post-challenge for pups. 
To evaluate entrapment of intestinal L1 in mucus, rats were euthanized 60 to 90 minutes 
post-challenge and the contents of stomach and small intestine (divided into the proximal 50% 
and distal 50% of the small intestine) were examined as previously described (24).  Briefly, 
intestinal contents were flushed with 0.85% NaCl, collected into 50 ml polypropylene conical 
tubes, and packed on ice.  L1 trapped in mucus were observed by pressing mucus between 
glass slides.  L1 free in saline were considered to have been free in the lumen.  Intestines were 
incubated at 37°C for 5 hours, and L1 migrating out of the epithelium were counted.  
Histology 
Two-centimeter sections of jejunum were collected, fixed in Carnoy’s solution (60% 
ethanol, 30% chloroform, 10% glacial acetic acid) for 3 hours, transferred to 70% ethanol, and 
embedded in paraffin.  Mast cells were counted in sections stained with Alcian blue (pH 0.4) and 
counterstained with Nuclear Fast Red.  Goblet cells and eosinophils were counted in sections 
stained with hematoxylin and eosin (H & E). Each cell type was counted in twenty crypt-villus 
units (CVU) per rat, and values reported as the mean number per CVU for rats in each treatment 
group.
Sera and antibodies
Tyvelose-specific monoclonal antibodies 9D4 (IgG1), 18H1(IgG2a), and 9E6 (IgG2c) 
have been described previously (21). Antibodies were concentrated by (NH4)2SO4 precipitation 
of nude mouse ascites fluid, dialyzed against saline, and were adjusted to a concentration of 5 
mg/ml  (21). Immune serum was collected from adult AO rats 9 to 12 weeks following infection 
with 1000 L1.  Normal rat serum was collected from naïve rats. Polyclonal IgG was produced 
by precipitation of immune or normal serum with 40% (NH4)2SO4 leaving polyclonal IgE in 
the supernatant (31). Both fractions were dialyzed against saline and concentrated to match the 
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original volume of serum using a 10,000 molecular weight cut-off centrifugal device (Millipore-
Centricon, Billerica, MA). 
ELISA
Serum antibodies were measured using T. spiralis excretory-secretory antigen (32) or 
anti-IgE (clone A2) (33) for capture, and biotinylated mouse anti-isotype antibodies followed 
by horseradish peroxidase-conjugated streptavidin. Antibodies were detected with biotinylated 
monoclonal mouse anti-rat IgG1 (RB11/39), IgG2a (RG7/1), IgG2b (RG7/11), or IgE 
(MARE-1).  Antibodies were biotinylated with N-hydroxysuccinimidobiotin (Sigma; St Louis, 
MO) in bicarbonate buffer (pH 9.5; 120 µg biotin per 1 mg of antibody) for 4 hours at room 
temperature and used at 1 µg/ml.  Biotin-conjugated anti-rat IgG2c (BD Pharmingen; San Diego, 
CA) was used at 0.25 µg/ml .  Standard curves for IgG1, IgG2a, IgG2b, and IgG2c utilized 
tyvelose-specific monoclonal antibodies 9D4, 18H1, 10G11, and 9E6, respectively. Sera from 
rats were diluted 1:6000 for measuring IgG1 and IgG2a, 1:100 or 1:500 for IgG2b, or 1:2500 
for IgG2c. In order to measure total serum IgE, ELISA plates were coated with anti-rat IgE mAb 
A2 (5 µg/ml) rat myeloma IgE 162 (34) served as a standard, rat sera were diluted 1:100, and 
biotin-conjugated MARE-1 (5 µg/ml) was used as the detection reagent. RMCPII was detected 
in rat sera using the RMCPII ELISA kit purchased from Moredun Scientific Limited (Midlothian, 
Scotland).
Passive immunization of rat pups
 One hour prior to oral infection with L
1, 
groups of 6 to 8 rat pups were fed 
antibodies (5 mg/ml in 0.85% NaCl) at a dose of 2.5mg/20g of body weight. Antibody treatments 
included serum immunoglobulin from infected or uninfected rats, tyvelose-specific mAb, and 
precipitates or supernatants from immune serum.  Pups treated with whole serum or serum 
fractions were fed two doses of 0.5 ml, two hours and one hour prior to challenge infection. 
Adult rats were passively immunized by intraperitoneal injection of 5 mg of tyvelose-specific 
mAb or normal serum immunoglobulin and challenged orally 16 hours later.
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Statistical analyses
Student’s t test was used to compare means for treatment groups. Analysis of variance 
and Tukey’s least significant difference test were used to detect differences among three or 
more means. Data are presented as mean ± standard deviation (n = 5-8 rats).  In experiments 
where pups of infected dams were challenged, means were calculated for each litter and those 
values assigned to the dam in order to calculate the mean for the treatment group. For passive 
immunization experiments, rat pups in each group were selected from a randomized pool from 
several litters. Differences were considered significant when the p-value was less than 0.05.
Results
 Immunity induced by intravenous infection is indistinguishable from rapid expulsion.
Infection with T. spiralis occurs when a host ingests muscle tissue containing T. spiralis 
L1. Infection begins when L1 invade epithelial cells lining the small intestine, where they molt 
four times to become adult worms (35). Adult worms in this epithelial syncytium mate, and the 
females release NBL, which enter the blood stream and subsequently establish a chronic muscle 
infection. We have shown previously that rats infected by intravenous injection of NBL develop 
muscle infections that engender immunity against re-infection of the intestine (36).  In order to 
confirm that this immunity was equivalent to rapid expulsion induced by natural infection, we 
evaluated the distribution of larvae in the period immediately following challenge infection. 
Mucus entrapment of luminal larvae within the first hour of challenge is a hallmark of rapid 
expulsion (27, 37). Such entrapment occurred in both parenterally and orally infected rats after 
oral challenge (Fig 2.1A).  In both groups, L1 were excluded from the small intestinal epithelium, 
as evidenced by increased numbers of L1 in the lumen of the distal intestine (Fig 2.1B) and 
dramatically fewer larvae recoverable from the epithelium (Fig 2.1C), compared to naïve control 
animals. Intestinal burdens were not further reduced between 24 and 72 hours post-challenge, 
indicating that the response was specific and restricted to larval, rather than adult, stages (Fig. 
2.1D). The increased number of worms recovered from naïve rats at 72 hours post-challenge can 
46
A B
Proximal Proximal Proximal Distal Distal Distal 
24 hours
post-challenge
72 hours
post-challenge
p<0.05
p<0.05
p<0.05
p<0.05
p<0.05
0
75
150
Natural
Muscle
Naive
M
u
cu
s-
tr
ap
p
ed
 l
ar
v
ae
0
40
80
Natural
Muscle
Naive
L
u
m
en
al
 l
ar
v
ae
0
150
300
Natural
Muscle
Naive
E
p
it
h
el
ia
l 
la
rv
ae
0
250
500 Naive
Muscle
In
te
st
in
al
 l
ar
v
ae
C
D
FIGURE 2.1. Intestinal immunity induced by muscle infection. (A-C) Distribution of larvae 
in previously infected and naïve AO rats sixty to ninety minutes post-challenge with 500 L1.  
Rats were infected intravenously with 80,000 NBL  (muscle) or with 1000 L1 (natural). Proximal 
and distal small intestine contents were collected separately, and larvae were counted that were 
(A) trapped in mucus, (B) free in the intestinal lumen or (C) able to migrate into saline from 
the epithelium. (D) Intestinal burdens in naïve rats and rats immunized by muscle infection.  
Burdens were stable after 24 hours, indicating that immunity was specific for larval stages.
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be explained by the failure of molting larvae (present in the intestine 24 hours post-infection) 
to emerge from the intestinal epithelium. Overall, the kinetics of entrapment and exclusion 
following intestinal challenge of parenterally infected rats are entirely consistent with rapid 
expulsion.
Oral challenge of parenterally infected rats causes mast cell degranulation in the absence of 
mastocytosis.
We sought to evaluate the cellular response in the intestine after parenteral infection, 
including evaluation of mast cell degranulation upon challenge infection. Jejunal mast cells, 
eosinophils, and goblet cells were not increased in parenterally infected rats (Fig. 2.2A, B, C), 
although there was a mild but prolonged blood eosinophilia (Fig. 2.2D). Despite the absence of 
intestinal mastocytosis, oral challenge of parenterally infected rats induced a significant increase 
in serum RMCPII concentration (Fig. 2.2E) that correlated with larval expulsion (Fig. 2.2F). The 
amount of RMCPII detected in parenterally immunized rats was consistent with what we have 
detected in orally immunized rats in several other experiments (1,000 - 2,000 ng/mL). These 
results reveal that degranulation of mucosal mast cells was coincident with expulsion, even in 
the absence of mastocytosis.  Attempts to inhibit mast cell degranulation by treating rats with the 
mast cell stabilizer, doxantrazole, were unsuccessful.  Therefore, we were unable to determine 
whether mast cell activation contributed to rapid expulsion.
Comparison of antibody responses between naturally and parenterally infected rats 
revealed a striking difference.  Infection limited to the muscle did not cause a significant increase 
in the total serum concentration of IgE, but did induce a strong parasite-specific IgG2a response 
(Fig. 2.2G,H). Both IgE and IgG2a bind to the high affinity IgE receptor, FceRI (38), so it is 
possible that mast cell activation was mediated by IgG2a in parenterally infected rats and by both 
isotypes in naturally infected rats.  Either infection regime induced antigen-specific IgG1 and 
IgG2c (Fig. 2.2H, I), two isotypes known to mediate rapid expulsion in rat pups (21).
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FIGURE 2.2. Cellular and antibody responses to muscle infection. Intestinal sections from 
rats immunized via muscle infection were evaluated for (A) mastocytosis, (B) eosinophilia, and 
(C) goblet cell hyperplasia. (D) Blood eosinophilia during infection. (E) RMCPII concentrations 
in sera collected 30 to 90 minutes post-challenge. (F) Intestinal burden 24 hours after challenge 
with 500 L1 in naïve rats and rats immunized with muscle infection. (G-I) Serum antibodies 9 
weeks following infection with 1,000 L1 or 80,000 NBL. 
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Parenteral immunization generates a T cell-dependent mucosal response.
Mastocytosis in T. spiralis infection is T cell-dependent (39, 40). Because intestinal 
mastocytosis was not required for rapid expulsion, and knowing that IgG2c mediates rapid 
expulsion in rat pups and can be produced in a T-cell independent manner (41), we tested the 
requirement for T cells in rapid expulsion by challenging parenterally infected, T cell-deficient 
rats.  Only euthymic rats demonstrated rapid expulsion, indicating that T cells were required for 
immunity (Fig. 2.3). Similar results were obtained in PVG rats made T lymphocyte-deficient 
by thymectomy, followed by irradiation and bone marrow reconstitution (data not shown).  In 
another experiment, we passively immunized parenterally infected rnu/rnu rats with monoclonal, 
tyvelose-specific IgG1.  These animals did not demonstrate rapid expulsion, a result that is 
consistent with a requirement for T cells in addition to antibody production (data not shown). 
Blood RMCPII was not elevated in nude rats following challenge, consistent with a failure of 
both T lymphocytes and T-dependent, antibody production (data not shown).
Mast cell degranulation is coincident with rapid expulsion in rat pups fostered by infected 
dams.
With the aim of using suckling rat pups to study secondary expulsion of T. spiralis, we 
evaluated mast cell degranulation in this system. Rat pups fostered by a dam infected with T. 
spiralis demonstrate rapid expulsion (20, 42).  Passive immunization with tyvelose-specific 
mAbs confers immunity upon pups born to naïve dams (21). Antibodies delivered immediately 
prior to infection are protective, indicating that cells that may interact with antibodies to effect 
expulsion are resident in the normal neonatal rat gut.  We evaluated MMC degranulation 
in rat pups that displayed rapid expulsion (Fig. 2.4A).  Prior to challenge, serum RMCPII 
concentrations were similar in pups born to infected dams compared with pups of naïve dams 
(Fig. 2.4B).  When both groups were challenged with 200 L1, only pups born to infected dams 
showed significantly elevated serum RMCPII concentrations (Fig. 2.4B).  Thus, maternal 
immunity confers upon pups the capacity to activate mast cells upon oral infection with T. 
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FIGURE 2.3. Evaluation of intestinal immunity induced by muscle infection in nude rats. 
Athymic nude (rnu/rnu) rats and euthymic (rnu/+) littermates were immunized by intravenous 
injection of 30,000 NBL. Uninfected PVG strain rats served as controls. Rats were challenged 
orally with 500 L1 9 weeks after muscle infection. Intestinal parasite burden was determined 24 
hours after challenge.
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FIGURE 2.4. Mucosal mast cell degranulation in rat pups born to infected dams.2 (A) 
Rat pups born to a naturally infected dam exhibit rapid expulsion upon challenge infection. 
(B) RMCPII concentrations in sera of pups born to infected and uninfected dams. Pups were 
unchallenged (ø) or challenged orally with 200 L1. Blood was collected 3 hours post-challenge. 
Mean RMCPII concentration in sera of challenged pups of immune dams is significantly higher 
than all other groups (p <0.01). 
 
2Experiments performed by L.K. Blum and others.
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spiralis.
RMCPII release does not correlate with rapid expulsion in passively immunized rat pups.
Since the antibody isotypes that provide immunity to rat pups are not the same isotypes 
known to cause mast cell degranulation in rats, we were able to manipulate this system to 
separate mast cell degranulation from protective immunity. Pups were fed tyvelose-specific 
mAbs of different isotypes one hour prior to oral challenge (Fig. 2.5). Treatment with IgG2c 
afforded protection but did not cause a significant increase in serum RMCPII concentration. 
Conversely, IgG2a caused a significant release of RMCPII, but did not provide protection.  Pups 
treated with IgG1 were protected and modest increases in serum RMCPII were induced.  These 
results indicate that MMC degranulation is not required for rapid expulsion.  Furthermore, 
activation of mast cells by IgG2a was not sufficient to cause rapid expulsion.  
To test whether the effects observed were unique to mAbs, pups were fed fractions of 
serum enriched for either IgE or IgG.  IgG precipitates in 40% saturated (NH4)2SO4, while IgE 
remains soluble (31).  As shown in Figure 2.6, whole immune serum and precipitated IgG from 
immune serum caused rapid expulsion, while the supernatant was not protective, as we have 
shown previously (26) (Fig. 2.6A). Administration of serum or fractions of serum did not cause 
RMCPII release prior to challenge with parasites (Fig. 2.6B).  Following challenge, pups treated 
with any fraction of immune serum had elevated concentrations of RMCPII in their sera (Fig. 
2.6C). These results confirm that RMCPII release is not sufficient to cause rapid expulsion. 
RMCPII release is not sufficient to cause rapid expulsion in passively immunized adult rats
 We continued these studies by investigating whether the dissociation of mast cell 
degranulation from rapid expulsion was possible in adult rats. Five- to six-week old rats (weaned 
at 3 weeks of age) were injected intraperitoneally with tyvelose-specific mAbs 16 hours prior to 
oral challenge with L1 (Figure 2.7). We have previously reported that although treatment with 
tyvelose-specific IgG2c is not protective in weaned rats, it causes L1 to become encumbered 
in the intestinal epithelium such that parasites are not released into saline during the standard 
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FIGURE 2.5. RMCPII release in rat pups passively immunized with parasite-specific 
monoclonal antibodies.3 (A) Intestinal larvae in passively immunized pups 3 hours post-
challenge. (B) RMCPII concentration was measured in serum collected prior to challenge or 
3 hours post-challenge.   Values in IgG1 treated rats were reproducibly elevated in replicate 
experiments, although not to the level of statistical significance.
3Experiments performed by L.K. Blum and others.
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FIGURE 2.6. RMCPII release in rat pups treated with fractions of serum from infected 
rats.4 Rat pups were left untreated (ø) or were treated orally with (NH4)2SO4 precipitate (P), 
supernatant  (S) or whole serum (W) collected from naturally infected or naïve rats. (A) 
Intestinal burden in pups treated with serum fractions and challenged orally with 200 L1. (B) 
RMCPII concentrations in sera of passively immunized pups prior to challenge. (C) RMCPII 
concentrations in sera of passively immunized pups 3 hours post-challenge with 200 L1.
4Experiments performed by L.K. Blum and others.
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recovery procedure. This effect is reversed at the time of the first molt (25). In the experiment 
shown in Figure 2.7, we also measured serum RMCPII, and found that the protease was 
significantly increased in rats treated with IgG2a but not those treated with IgG2c (Figure 2.7B). 
IgG2a-treated adult rats did not expel the infection, despite the increase in RMCPII (Figure 
2.7A).  The results confirm that immunity is independent of RMCPII release.
Discussion
Rapid expulsion is a rare example of an immune response that causes immediate 
elimination of an intestinal worm. Elucidation of the mechanism of immunity would afford 
valuable insight applicable to the development of new prophylactic measures that would 
protect humans and animals against nematode infection. The effort to elucidate the mechanism 
of immunity in rapid expulsion has been challenged by the combinatorial nature of immune 
mechanisms in adult rats.  Several studies that tested adoptive transfer of lymphocytes or passive 
immunization with specific antibodies failed to fully replicate rapid expulsion in adult recipients 
(29, 43, 44), suggesting that innate mediators contribute to immunity.  In this report we show that 
rapid expulsion can be induced by an infection limited to the muscle phase and that immunity is 
T lymphocyte-dependent.   We investigated whether this T-dependent effect involved mucosal 
mast cells or intestinal mastocytosis.
Previous studies showed a correlation between T. spiralis expulsion and mucosal mast 
cell degranulation, but a specific mediator or causal relationship was not identified (2-4, 45). 
Rats maintain a resident population of mucosal mast cells in the lamina propria of the small 
intestine under homeostatic conditions (46). It has been suggested that mast cell activation might 
be a direct effect of the parasite, and such activation has been demonstrated in vitro following 
exposure of cultured mast cells to tyvelose-bearing T. spiralis antigens (47, 48).  In contrast, 
we found that parasite challenge in the absence of specific antibodies did not cause significant 
RMCPII release.  The kinetics of RMCPII release in immune rats was consistent with antibody-
dependent activation.   In rats displaying rapid expulsion following immunization via muscle 
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FIGURE 2.7. RMCPII release in passively immunized adult rats.5 Adult rats were 
injected intraperitoneally with 5 mg of tyvelose-specific IgG2c or IgG2a, or normal serum 
immunoglobulin (negative control). (A) Intestinal larvae burden and (B) serum RMCPII 
concentration were determined at 3 and 24 hours post-challenge with 500 L1.
5Experiments performed by L.K. Blum and others.
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infection, IgG2a was the isotype most likely to cause degranulation, while in orally infected 
rats IgE was present in high concentrations.  The differences in immune responses induced by 
intestinal and muscle infection reduces the likelihood of a role for two other innate mediators, 
goblet cells and eosinophils. Both have been hypothesized to contribute to rapid expulsion.
Throughout the published literature describing rapid expulsion, the most consistent 
protective effects are attributed to antibodies (49). Rapid expulsion displayed by neonatal 
rat pups born to infected dams can be reproduced in pups born to naïve dams by passive 
immunization with tyvelose-specific IgG (21). The protective mechanisms of the antibodies 
have been documented in vivo (21, 24) and confirmed in an in vitro model (23). Direct effects 
of antibodies on T. spiralis larvae include entrapment of larvae in mucus as well as exclusion 
from and encumbrance in the epithelium (23, 24).  The potential for mast cells to contribute to 
antibody-mediated protection has not been investigated previously in neonatal rats. Furthermore, 
the functional activities of mucosal mast cells in neonatal rats had not been tested in the context 
of infection.
We found that rat pups born to infected dams demonstrated mast cell activation 
coincident with rapid expulsion.  Passive immunization allowed for the separation of RMCPII 
release from rapid expulsion.  It has been established that passive immunization with tyvelose-
specific monoclonal IgG1 or IgG2c confers protection on rat pups, while monoclonal IgG2a 
and polyclonal IgE are not protective (20, 21, 26).  Thus, the isotypes known to cause mast 
cell degranulation via FceRI crosslinking (38, 50), and shown to induce release of RMCPII in 
our experiments, do not protect pups.  Our results show that rat mucosal mast cells are weakly 
activated by IgG1.  IgG1 binds the FceRI (Thrasher and Appleton, unpublished observation) 
although reports of receptor-mediated activation of mast cells by IgG1 are contradictory (38, 
50).  It is possible that rat mucosal mast cells are activated by IgG1 via binding to other FcR 
or by some indirect mechanism, such as complement activation. Experiments with IgE rich 
serum fractions provided confirmation that release of RMCPII was not sufficient to cause rapid 
expulsion. Conversely, passive immunization with IgG2c was protective but did not induce 
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RMCPII release, indicating that expulsion of larvae can occur independently of mast cell 
activation. RMCPII release caused by IgG2a was not sufficient to provide a protective secondary 
immune response to adult rats. Overall, our results do not support a role for RMCPII or mast 
cells in rapid expulsion. 
Support for the conclusion that mast cells are not pivotal in rapid expulsion was provided 
by studies using pharmacological agents that block histamine, serotonin, prostaglandins, and 
intestinal motility (45).  Treatment of infected adult rats with inhibitors of various mast cell 
effectors did not prevent rapid expulsion.  The speed of expulsion would not allow for de novo 
synthesis of mast cell proteins, although cytokines that are pre-stored by mast cells, such as 
TNFa, may play a role (51). While mMCP-1 promotes adult worm rejection in mice, our results 
show that release of the equivalent mediator, RMCPII, is not required for rapid expulsion of T. 
spiralis in rat pups, and that release of RMCPII can occur in pups and adults without causing 
expulsion.
Infection limited to the muscle phase induced rapid expulsion in the absence of 
intestinal priming and the cellular changes priming induces. While this suggests that systemic 
immunization against a parasitic nematode produced a mucosal immune response, it must be 
noted that NBL are efficiently delivered to the lung via intravenous injection and some NBL may 
reach the intestine via the bloodstream. Efforts to inject NBL directly into the muscles of the hind 
limbs in numbers sufficient to induce immunity consistently allowed a small proportion of NBL 
to enter the blood and colonize remote sites (Blum and Appleton, not shown) thus preventing 
us from determining whether migration through the lung or other tissues was necessary for the 
induction of immunity.  Although we did not detect the obvious cellular changes in the intestines 
of rats infected by this route, it is possible for stimulation of mucosal associated lymphoid tissue 
(MALT) in one site to affect another site. An additional source of cellular mediators may derive 
from the body cavities where cellular expansion during muscle infection has been documented 
in mice (52, 53). Recirculation of cells from the cavities to the intestinal tract, or direct effects 
of peritoneal responses on the gut have been shown to be a part of the body’s defense against 
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intestinal pathogens (54).  The diaphragm is a preferred site for developing T. spiralis larvae and 
the interaction between cavity cells and the parasite in this location may drive subtle alterations 
in the intestine. Such alterations may differ from those that are commonly associated with 
nematode infection such as eosinophilia, goblet cell hyperplasia or mastocytosis.  
Taken together, results from parenteral infection of adult rats and passive immunization 
of neonates and adults demonstrate that both IgE and IgG2a activate mast cells during rapid 
expulsion. Our data support the conclusion that neither mastocytosis nor release of RMCPII are 
required for rapid expulsion. Identification of the factor that enables antibodies to protect adult 
rats requires further investigation.  Our results have significance for the development of vaccines 
against helminths, as they show that protective immunity can be engendered without inducing a 
potentially dangerous allergic response to antigen. 
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Chapter 3
Intestinal infection with Trichinella spiralis induces distinct, regional immune 
responses1
1  Originally in Veterinary Parasitology.
Blum L.K., Mohanan S., et al. 2011. Vet Parasitol. (submitted for publication)
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Abstract
The aim of this study was to evaluate differences between the small and large intestines 
(SI and LI) with regard to colonization and immunity during infection with Trichinella spiralis. 
In orally infected C57BL/6 mice, the gender ratios of worms differed among the SI, cecum, and 
LI. Mucosal mastocytosis developed in the SI but not in the LI, consistent with reduced IL-9 
and IL-13 production by explants from the LI. Despite these differences, worms were cleared 
at the same rate from both sites. Furthermore, IL-10 production was reduced in the LI, yet it 
was instrumental in limiting local inflammation. Finally, passive immunization of rat pups with 
tyvelose-specific antibodies effectively cleared fist-stage larvae from all intestinal regions. We 
conclude that despite regional differences in immune responsiveness and colonization, immune 
mechanisms that clear T. spiralis operate effectively throughout the intestinal tract.
Introduction
 Regions of the vertebrate intestine differ with regard to size, physiology, and 
microbial flora. In addition, the SI and the LI constitute distinct immune environments, with 
differences in regulatory T cell phenotypes and the production of IL-10 and TGF-β (6, 19). 
Endothelial cells displaying MAdCAM-1 recruit α4β7-expressing lymphocytes throughout 
the intestine, while CCR9-bearing lymphocytes are selectively recruited to the SI by locally 
produced CCL25/TECK (14). In this way, immune responses can be directed to the SI. Although 
many parasites are restricted in their distribution in the gastrointestinal tract, Trichinella spiralis 
colonizes both the small and large intestines (10, 21), providing an opportunity to investigate 
variation in regional immune responses and the impact this may have on infection. 
Materials and Methods
Animals
 C57BL/6NHsd and BALB/cNHsd were purchased (Harlan, USA) and IL-10 deficient 
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(B6.129P2-IL10tm1Cgn) mice and Albino Oxford (AO) rats were bred and maintained under 
specific pathogen-free conditions according to the guidelines of the Association for Assessment 
and Accreditation of Laboratory Animal Care. Experiments were performed with the approval of 
the Cornell University Institutional Animal Care and Use Committee. 
Parasite and infections
Maintenance of Trichinella spiralis (pig strain), L1 recovery, and intestinal worm burden 
estimation were carried out as described (9, 13). Adult mice (7 to 10 weeks old) or suckling 
rat pups (12 to 16 days old) received 400 or 200 L1 by gavage, respectively. Crude L1 parasite 
extract (cAg) was prepared as described (4). 
Tissue collection, preparation, and evaluation
Mice were euthanized with C02. The SI and LI were removed and cut longitudinally, 
prepared as swiss rolls (20), fixed in Carnoy’s solution, and sectioned for staining with Alcian 
Blue (pH 0.4) and Nuclear Fast Red. Alternatively, tissues were fixed in formalin prior to 
sectioning and staining with Hematoxylin and Eosin. Mast cells in Alcian Blue-stained sections 
were estimated per crypt-villus unit (CVU) in a minimum of 50 CVU per section. Scoring of 
enteropathy in H & E-stained sections was as follows: epithelial hyperplasia (0-3), severity 
of inflammation (0-4); the sum of these two scores was multiplied by a value assigned to 
the distribution of inflammatory foci (0-3) for a total score ranging from 0 to 21. Severity of 
inflammation was defined as follows: no significant inflammation - 0; cellular infiltrate within the 
lamina propria, mild - 1, moderate - 2, severe and extending into the submucosa - 3; severe with 
crypt abscess, goblet cell depletion, and ulceration - 4. Neutrophil infiltration was given a score 
from 0 (no infiltration) to 3 (severe infiltration). Microscopy and image capture were performed 
with an Olympus BX51 microscope and DP25 camera, using Microsuite Basic Edition software.
Antibody treatment of rat pups
Monoclonal, tyvelose-specific IgG1 (clone 9D4) and polyclonal IgG (nIgG) were 
prepared as described previously (1, 3). Rat pups were treated with 2.5 mg of antibody per 20 g 
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of body weight by gavage, challenged one hour later, and intestinal parasite burdens estimated 
after 24 and 48 hours (9).
Cytokine Measurement
Five mm pieces of jejunum, ileum, or LI were weighed prior to processing for explant 
cultures, as described (11). Explants were cultured with 50 μg/mL of cAg for 16-18 hours at 
37°C. Explant supernatants were centrifuged at 138 x g and assayed for IL-4, IL-5, and IL-
10 by ELISA as described previously (7). The same protocol was applied to measure IL-9 
(BD Biosciences: 2.5 μg/mL capture clone D8402E8, 0.25 μg/mL detection antibody clone 
D9302C12), IL-13 (Ebioscience: 2 μg/mL capture clone ebio13A, 0.2 μg/mL detection antibody 
clone eBio1316H), IL-17A (BD Biosciences: 2 μg/mL capture clone TC11-18H10, 0.17 μg/mL 
detection antibody clone TC11-8H4.1), and IFN-g (BD Biosciences: 1 μg/mL capture antibody 
clone AN-18; Ebioscience: 0.125 μg/mL detection antibody clone XMG1.2). Recombinant 
cytokine standards were purchased (Ebioscience). 
Statistical analysis
Experiments were performed twice and data were evaluated using Student’s t test or 
ANOVA with Tukey’s post-hoc test for multiple means. P-values less than 0.05 were considered 
to be statistically significant.
Results
Distribution of T. spiralis in the intestinal tract
 Previous reports have documented the presence of T. spiralis in the large 
intestine; however, the location of the worms in the tissue has not been described. Ten days post-
infection (dpi), adult worms occupied an epithelial habitat similar to that observed in the small 
intestine (Figure 3.1A)(23). Peak worm burdens occurred prior to day 5 in the SI, on day 9 in 
the cecum, and on day 13 in the LI (Figure 3.1B, C, D). Once established, worms were expelled 
at comparable rates from each site. Results obtained from C57BL/6 and BALB/c mice were 
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Figure 3.1: Colonization and expulsion of intestinal T. spiralis. (A) Cross section of adult T. 
spiralis in an H&E stained section of the LI from a C57BL/6 mouse. Arrow indicates the para-
site. (B-D) Parasite colonization and expulsion from the three compartments of the intestine in 
C57BL/6 and BALB/c mice infected orally with 400 L1. (E-G) Numbers of male and female 
worms in C57BL/6 mice. P-values represent differences between the numbers of male and fe-
male worms(n = 4 mice per group, means compared using Student’s t-test).
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indistinguishable.
 The ratio of female to male T. spiralis colonizing the SI has been reported to 
be approximately 2:1, shifting to 1:1 as worms are expelled (15). Figure 3.1 (panels E, F, G) 
shows the expected transition in gender ratio in the SI of C57BL/6 mice, while equal numbers of 
male and female parasites were observed at all times in the cecum and LI. Similar results were 
obtained from BALB/c mice (not shown). These results suggest that females are cleared more 
rapidly from the SI and are less successful than males in colonizing the distal compartments.  
Cytokine production and mast cell response
 Assay of cytokines in explant cultures revealed no significant differences in IL-4, 
IL-5, or IFN-g among the jejunum, ileum, and LI (Figure 3.2A). Although colonization of the 
sites was not synchronous, the response kinetics were similar for these cytokines across the 
sites. In contrast, IL-9, IL-10, and IL-13 were significantly lower in LI explant cultures, and the 
modest output of these cytokines was delayed compared to the SI. IL-17 was reproducibly lower 
in the LI only at 15 dpi. 
In the context of T. spiralis infection, intestinal mastocytosis in the SI of mice is driven 
by IL-9 and IL-10 (12, 17), and mast cells are believed to be essential to the mechanism of worm 
expulsion (16, 18). The absence of a significant increase in Alcian Blue positive cells in the 
LI during infection (Figure 3.2B) correlated with reduced production of IL-9 and IL-10 in that 
compartment. Despite these deficiencies, worms were expelled at a rate similar to that observed 
in the SI. Thus, the immune response to T. spiralis in the LI is significantly different from that of 
the SI, and does not feature mastocytosis, yet expulsion occurs in a timely manner.
Enteropathy and the influence of IL-10 
 In C57BL/6 mice, inflammation in the SI increased dramatically during infection, 
while no reproducible inflammatory response was detected at any time in the LI (Figure 3.3). 
In contrast, inflammation increased significantly on day 10 of infection in the LI of IL-10-/- 
mice, and this inflammation resolved by day 15. We concluded that IL-10 is a key regulator of 
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Figure 3.2: Cytokine and mast cell responses in the SI and LI. (A) Cytokines in culture super-
natants of tissue explants cultured with crude parasite extract. Values are expressed as picograms 
of cytokine per milligram of tissue. P-values indicate significant differences between LI and jeju-
num (black) or LI and ileum (gray) (n = 4 mice per group, means compared using ANOVA with 
Tukey’s post-test). (B) Intestinal mast cells in SI and LI during the course of infection. Values 
represent the mean number of mast cells per crypt-villus unit (CVU) estimated from a minimum 
of 50 CVU per mouse. P-values indicate a significant increase in the SI relative to uninfected 
mice, with no significant changes in the LI (n = 3 mice per group, means compared using ANO-
VA with Tukey’s post-test). 
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Figure 3.3: Enteropathy in C57Bl/6 and IL-10-/- infected with T. spiralis. H&E preparations 
were scored using a 21-point scale (see text). (A) SI (B) LI. P-values represent significant differ-
ences relative to uninfected mice (n = 4 mice per group, means compared using Student’s t-test).  
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inflammation in the LI during T. spiralis infection, and that an IL-10-independent regulatory 
mechanism functions in the LI to quickly resolve inflammation, while SI enteropathy persists. 
 To further evaluate the importance of IL-10 in regulating immunity, we measured 
the cytokines produced by tissue explants from IL-10-/- mice (Figure 3.4A). These mice were 
tested in parallel with C57BL/6 mice, allowing direct comparison of results graphed in Figures 
2 and 4. Explants from IL-10-/- and C57BL/6 mice yielded nearly identical cytokine quantities, 
with the exception that IL-17 production by SI explants was significantly greater in IL-10-/- mice. 
The increase in IL-17 was correlated with a significantly greater influx of neutrophils in IL-
10-/- mice at day 15 pi (Figure 3.4B). Thus, IL-10 regulated IL-17 production in the SI but not 
the LI, and the increased inflammation observed in the LI of IL-10-/- mice did not correlate with 
alterations in the production of the cytokines assayed.
Protective immunity in the SI and LI 
 Previously infected rats display a dramatic protective immunity in which 90% 
of L1 are cleared from the intestine within an hour of challenge. Suckling rats display this rapid 
expulsion when passively immunized with antibodies specific for tyvelose (1, 2, 8). In order to 
determine whether rapid expulsion occurs in the LI, we estimated worm burdens in passively 
immunized pups after 24 (Figure 3.5A) or 48 (Figure 3.5B) hours. Treatment with specific 
antibody cleared parasites from all compartments, compatible with the conclusion that antibodies 
can effectively exclude or eliminate T. spiralis from epithelia in the cecum and LI.
Discussion
Immunity to T. spiralis is often compared with immunity to Trichuris muris, a cecal 
dwelling nematode. Although the two parasites are closely related, the mechanisms of worm 
clearance are distinct, with mast cells reported to play a prominent role in expulsion of adult 
T. spiralis while epithelial cell turnover and function appear to be key to clearance of T. muris 
(5, 16). The differences in effector mechanisms may be dictated by properties intrinsic to each 
parasite, or by their preferred locations in the intestinal tract. Although immunity induced by T. 
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Figure 3.4: Cytokine response in the SI and LI of IL-10-/- mice. (A) Cytokines in culture 
supernatants of tissue explants in IL-10-/- mice, expressed as picograms of cytokine per milligram 
of tissue. P-values indicate significant differences between LI and jejunum (black) or LI and 
ileum (gray), * represents a difference of p<0.05 between jejunum and ileum (n = 4 mice per 
group, means compared using ANOVA with Tukey’s post-test). 
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Figure 3.5: Protective immunity in the LI of suckling rats. Pups were treated with tyvelose-
specific IgG1 (9D4) or naive rat IgG (nIgG) one hour prior to challenge with 200 L1. (A) Parasite 
burden in the SI, or combined cecum and LI, 24 hours after challenge. (B) Parasite burden in 
the SI, or combined cecum and LI, 48 hours after challenge. P-values are shown for nIgG versus 
corresponding compartment in 9D4-treated pups (n = 4 rats per group, means compared using 
Student’s t-test).
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spiralis in the SI of mice and rats has been studied in depth, immunity in the LI has been largely 
overlooked. We set out to evaluate immunity in the small and large intestines within the context 
of a single worm infection in order to determine whether the mechanisms of immunity vary 
across intestinal compartments.
 We evaluated T. spiralis infection in two mouse strains and observed a pattern 
of rolling colonization and expulsion. Females were more numerous in the SI compared to the 
cecum and LI. Female T. spiralis are much larger than males (3-4 mm versus 1 mm in length), 
which may increase their susceptibility to physical disruption and nutritional deprivation. The 
reduced survival of female worms as the parasites migrate distally may necessitate the high 
female to male ratio that occurs in the SI at the onset of infection.
Adult worms move rapidly within the intestinal epithelium, destroying epithelial cells 
that they occupy (24). It is possible that as the habitable space in one section of intestine is 
diminished, the parasites are forced to migrate to more distal regions in order to find healthy 
cells. Alternatively, the immune response in the SI may make that site less hospitable to the 
worms, prompting migration to the immunologically naïve cecum and LI. Explant culture assays 
showed that although IL-4, IL-5, and IFN-g were produced in the LI at early time points, IL-9, 
IL-10, and IL-13 production was delayed or absent in that compartment. The distal movement of 
the parasites may occur due to the gradients of these cytokines along the cranial-caudal axis of 
the intestine. In C57BL/6 mice, inflammation was more robust in the SI than the LI at days 10 
and 15 pi, indicating that the LI may be a more permissive region for the parasite.
 Our results suggest that lymphocytes induced in the jejunum can home to the 
ileum and initiate a response there, but do not enter the LI simultaneously. Cytokine responses 
were different in the two sites, and IL-13 was not detected in the LI at any time. In addition, 
mucosal mastocytosis was evident in the SI but not in the LI, consistent with weak IL-9 and IL-
10 production by LI explants. Mast cells are believed to be essential for the mechanism of worm 
expulsion from the SI, and their absence in the LI, despite clearance of worms from this site, 
indicates that the mechanisms of protective immunity may differ between the SI and LI. 
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 Pathologic responses were also regulated distinctly in different sites. IL-10 has 
been widely studied for its role in suppressing intestinal inflammation. A major function of IL-
10 in the intestine is in controlling pathogenic IL-17-producing T cells (22, 25). Consistent with 
this, IL-17 production and neutrophil infiltration were greater in the jejunum and ileum of IL-10-/- 
mice relative to C57BL/6 controls during T. spiralis infection. Nevertheless, it was the LI that 
demonstrated strong control of enteropathy by IL-10. The interplay between IL-10 and IL-17 in 
the SI and LI during T. spiralis infection merits further attention. 
Our results demonstrate that mucosal mastocytosis and the cytokines that influence it 
are not prominent in the LI during worm expulsion, and that immunopathology is more tightly 
regulated in the LI than the SI. Thus, mechanisms of immunity and enteropathy vary in different 
regions of the intestine during helminth infection. 
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Chapter 4
Epithelial disruption impacts intestinal immunity to Trichinella spiralis
83
Abstract
 Trichinella spiralis is a highly destructive parasitic nematode that damages large 
numbers of epithelial cells during intestinal infection. We set out to investigate the impact of 
this damage on the adaptive immune response. Although MyD88 was influential in promoting 
Th2 responses, this was not well correlated with the presence of intestinal bacteria, and MyD88 
operated independently of TLR2 and TLR4. Parasite molecules with the potential to function as 
PAMPs did not activate murine or human TLRs. Of the remaining MyD88-dependent receptors, 
IL-18 is known to inhibit the Th2 response during T. spiralis infection, but the influence of 
another IL-1 family member, IL-33, has not been described. Mice deficient in ST2-/-, the receptor 
for IL-33, recapitulated the results obtained from MyD88-/- mice, supporting a role for IL-33 
as an amplifier of the Th2 response. IL-33 was constitutively expressed in intestinal tissue, 
was not upregulated during infection, and was detected in intestinal leukocytes and epithelial 
cells where it became concentrated in the nucleus within two days of infection. Array analysis 
revealed that this translocation was coincident with downregulation of genes targeted by NF-κB 
in the epithelium of RAG2-/- mice, while expression of genes that promote the response to TGF-β 
were increased. Nuclear IL-33 did not co-localize with NF-κB. Our results implicate IL-33 as 
an innate mediator of Th2 immunity in the intestine and offer a model that parallels the cellular 
redistribution of human IL-33 that has been reported in ulcerative colitis.
Introduction
 Despite a prodigious increase in the past 20 years in our understanding of how 
bacterial and viral pathogens induce Th1-driven immunity, innate drivers of the Th2 response 
remain poorly understood. Trichinella spiralis is a parasitic nematode that is a human pathogen, 
in addition to naturally infecting other mammalian species, such as rodents. During intestinal 
infection, T. spiralis travels rapidly in a multi-intracellular niche within the epithelium, leaving 
a path of cellular destruction in its wake (39, 66). Cell injury and death is likely to influence 
adaptive immunity, yet this aspect of infection has not been investigated.
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 Receptor recognition of pathogen-associated molecular patterns (PAMPs) by 
toll-like receptors (TLRs) is a common mechanism of innate defense. Such patterns have 
been identified in bacterial, viral, protozoan, and helminth pathogens (32, 61, 63). MyD88 is a 
signaling adaptor molecule that propagates the response to most TLRs as well as responses to 
IL-1 family members, including IL-18 and IL-33 (1, 35, 42). MyD88 binds to the intracellular 
TIR domain of these receptors (directly or via a bridging adaptor such as MAL), where it 
initiates a signaling cascade that ultimately leads to the activation of proinflammatory genes by 
the transcription factor NF-κB (14, 25). 
T. spiralis larvae secrete multiple immunogenic glycoproteins as they invade the 
intestinal epithelium, and the mechanism by which these glycans may be detected by the innate 
immune system, including the potential dependence on TLRs/MyD88, is not known (15, 22, 
49, 51). In addition, the intestinal epithelium is exposed to an enormous number of bacteria 
(100 trillion bacteria belonging to 1000 different species), yet these bacteria do not induce 
inflammation under homeostatic conditions (23, 54). Most gut bacteria remain physically 
separated from the epithelium by a 50 μm zone, maintained by the secreted antibacterial lectin 
RegIIIγ, and the presence of an intestinal parasite may disturb this protective zone, or alter the 
composition of the microbiota (31, 62). 
One inherent distinction between bacterial, viral, or protozoan pathogens and large 
parasitic nematodes is the physical destruction that can be caused by the size and mobility of 
worms (66). Danger-associated molecular patterns (DAMPs), such as IL-33 and HMGB1, can 
give rise to inflammation when released by necrotic cells (38, 47, 48). In addition to its role in 
the TLR pathway, MyD88 functions as an adaptor for the IL-1 family of cytokine receptors, 
including ST2, the receptor for IL-33 (42, 55). IL-33 differs from other IL-1 family cytokines in 
that it is a so-called ‘necrocrine’ cytokine, which is released in its active form by necrotic cells 
(3, 38, 71). IL-33 is mainly expressed in fixed tissue cells such as epithelial and endothelial cells, 
adipocytes, astrocytes, and airway smooth muscle cells, although it may also be expressed by 
mast cells, dendritic cells, and monocytes under inflammatory conditions (28, 44, 45, 50, 65, 68, 
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69). 
In addition to its role as a paracrine cytokine, IL-33 also carries out an intracellular 
signaling mechanism, which is not well-understood (16). In many tissues, IL-33 is constitutively 
located in the nucleus, where it binds to the histone H2A/H2B acidic pocket, and is released in 
response to inflammatory stimuli (36, 53). In addition, it was recently reported that nuclear IL-33 
binds to NF-κB and prevents it from acting as a transcriptional activator (2); however, many of 
the studies regarding IL-33 nuclear translocation have been carried out in transfected cell lines, 
which may not be an accurate model of the in vivo functions of nuclear IL-33. 
Disruption of the epithelium by T. spiralis could promote Th2 immunity by the detection 
of parasite-derived glycoproteins, by altering the composition or location of the microbiota, or by 
the release of DAMPs from damaged host cells. We set out to investigate the innate response to 
epithelial cell destruction in order to identify drivers of Th2 immunity in the small intestine. 
Materials and Methods
Mice and Rats
MyD88-/- mice on a C57BL/6 background developed by Dr. S. Akira (Osaka University, 
Osaka, Japan) were generated by (♀ +/- by ♂ +/-) or (♀ +/- by ♂ -/-) crosses, and genotyped as 
previously described (59). MyD88+/+ littermates served as controls. TLR2/4-/- mice on a C57BL/6 
background were also generated by Dr. Akira. C57BL/6 mice and RAG2-/- mice were purchased 
from Taconic (USA). Mice were bred and/or maintained at Cornell under specific pathogen-
free conditions according to the guidelines of the Association for Assessment and Accreditation 
of Laboratory Animal Care. Albino Oxford (AO) rats were used as parasite donors, and were 
produced and maintained under specific pathogen-free conditions. Animals were infected at 
7-10 weeks old. Rodents were euthanized by CO2 inhalation, and blood was collected by cardiac 
puncture. Experiments at Cornell were performed with the approval of the Cornell University 
Institutional Animal Care and Use Committee. 
ST2-/- mice were originally provided by Dr. Andrew McKenzie (Laboratory of Molecular 
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Biology, Medical Research Council, Cambridge, U.K.) (12). ST2-/- mice were bred and 
maintained at Trinity College Dublin; animals were housed in a specific pathogen-free facility in 
individually ventilated and filtered cages under positive pressure. Experiments were performed 
in compliance with Irish Department of Health and Children regulations and approved by the 
Trinity College Dublin’s BioResources ethical review board.
Parasite and infections
Maintenance of Trichinella spiralis (pig strain), L1 recovery, and intestinal worm burden 
estimation were carried out as described (11, 26). Mice (7 to 10 weeks old) were infected with 
400 L1 by oral gavage. Crude L1 parasite extract, ES antigens, and purified phosphorylcholine-
bearing proteins were prepared as described (4, 49). Muscle larvae burdens were assessed in 
whole carcasses as previously described (5).
Culture of leukocytes and cytokine ELISA
Cells from cervical lymph nodes (CLN) or mesenteric lymph nodes (MLN) were 
prepared, cultured, and supernatants were assayed for IL-4, IL-5, and IL-10 by ELISA as 
described previously (6). The same protocol was applied to measure IL-13 (Ebioscience: 2 μg/
mL capture clone ebio13A, 0.2 μg/mL detection antibody clone eBio1316H), IL-17A (BD 
Biosciences: 2 μg/mL capture clone TC11-18H10, 0.17 μg/mL detection antibody clone TC11-
8H4.1), and IFN-g (BD Biosciences: 1 μg/mL capture antibody clone AN-18; Ebioscience: 0.125 
μg/mL detection antibody clone XMG1.2). Recombinant cytokine standards were purchased 
(Ebioscience). Serum mouse mast cell protease-1 (mMCP-1) was measured using the MCPT-1 
(mMCP-1) Ready-SET-Go! kit (Ebioscience).
Histology
Samples of small intestine were cut longitudinally, prepared as swiss rolls (43), and fixed 
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in formalin for immunohistochemistry (IHC). For evaluation of skeletal muscle, tongues were 
fixed in formalin. IHC for iNOS, IL-33 [3 μg/mL polyclonal goat anti-IL-33 (R&D systems) with 
0.6 μg/mL biotinylated rabbit anti-goat antibody (Vector Labs)], and mmcp-1 [5 μg/mL rat IgG2b 
anti-mmcp-1 (R&D systems) with 1 μg/mL biotinylated rabbit anti-rat antibody (Vector Labs)] 
was performed as described (6). Mast cells in mMCP-1 stained sections were counted per crypt-
villus unit (CVU) for a minimum of 50 CVU per section. 
For immunofluorescent staining, paraffin sections were prepared as for IHC, and treated 
with an avidin-biotin blocking kit (Vector Labs). After blocking for one hour with 5% normal 
rabbit serum in PBS, 5 μg/mL of polyclonal goat anti-IL-33 (R&D systems) and biotinylated 
mouse IgG1 anti-NF-κB (Imgenex) diluted in 1% BSA/PBS were added and slides incubated 
for one hour. After washing three times with PBS, Alexa 488-rabbit F(ab)2 anti-goat and Alexa 
594-Streptavidin (Invitrogen - Molecular Probes) in 1% BSA/PBS were added and slides 
incubated for one hour, followed by three washes in PBS. All incubations were carried out at 
room temperature. Images were collected with a Nikon TE300 fluorescent microscope, using a 
Hamamatsu OrcaER charge-coupled-device camera, with different labels collected sequentially 
as separate channels. Images were analyzed using SimplePCI (Hamamatsu, Sewickley, PA). 
Paraffin sections from mice infected with Toxoplasma gondii, provided by Dr. C. Egan (Cornell) 
were used as a positive control for NF-κB staining.
Flow cytometry
Single cell suspensions were prepared from spleen, and eosinophils were stained using 
phycoerythrin-labeled Siglec-F (BD Pharmingen) using methods previously described (5).
TLR Transactivation Assay
HEK293 cells were transfected with a plasmid encoding the indicated TLR, as previously 
described (18). Cells were cultured overnight with crude parasite extract, ES antigens, or purified 
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phosphorylcholine-bearing proteins. Data were analyzed by determining the fold induction 
relative to the activation of a constitutive β-galactosidase reporter construct.
Antibiotic Treatment
C57Bl/6 mice were provided with drinking water containing 0.5 mg/mL Bacitracin and 
Streptomycin (Sigma Aldrich), ad libitum, starting one week prior to T. spiralis infection. This 
protocol has been previously characterized as clearing all culturable bacteria (20). We evaluated 
bacterial clearance by culturing fecal samples on LB agar plates under aerobic conditions. 
Quantitative PCR
Peyer’s patches were removed, and total RNA was isolated from the remaining whole 
intestinal tissue using the TRIZOL reagent (Invitrogen) with a PowerGen handheld homogenizer 
(Fischer Scientific). cDNA was prepared using the SuperScript III First-Strand cDNA Synthesis 
System (Invitrogen). A sample lacking reverse transcriptase served as negative control. IL-33 
expression was measured with TaqMan qRT-PCR (ΔΔCT method) using an ABI PRISM 7500 
Sequence Detection System with HPRT as the endogenous control. HPRT expression was not 
affected by infection (not shown). Primers and probes for IL-33 and HPRT were purchased from 
Applied Biosystems. 
Invasion Assay 
An in vitro assay of epithelial cell invasion by T. spiralis was performed in 100 mm2 petri 
dishes as described previously (15, 39). Briefly, DLD-1 cells (ATCC #CCL-221) were plated at 
1.8 x 105 cells per dish, and incubated overnight in 8% CO2 at 37°C. Confluent monolayers (2 x 
107 cells) were inoculated with 3000 T. spiralis L1 in warm agarose and larvae were allowed to 
invade the monolayer for 2 hours prior to removal of the parasites and agarose. Cell collection 
and separation of cytoplasmic contents were performed using the Nuclear Extract Kit (Active 
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Motif) according to the manufacture’s directions. After removal of the cytoplasmic fraction, total 
(soluble and insoluble) nuclear proteins were resuspended in a volume of Nuclear Extract Kit 
lysis buffer equal to the volume of the cytoplasmic fraction.
Western Blotting
Samples were denatured in sample preparation buffer with 2-mercaptoethanol by boiling 
for 5 minutes, resolved by SDS-PAGE, and transferred to nitrocellulose as described (21). 
Blocking was carried out for 4 hours at room temperature in Tris-buffered saline (TBS) with 
0.05% Tween-20 and 5% nonfat dry milk. Antibodies were diluted in blocking solution, and 
blots were washed with TBS containing 0.05% Tween-20. Blots were incubated with primary 
goat anti-human IL-33 (0.1 mg/mL, R&D Systems), mouse anti-Lamin B1 (0.2 mg/mL, Santa 
Cruz Biotechnology), or biotinylated anti-Tubulin-α (0.5 mg/mL, BioLegend) for 2 hours at 
room temperature. Streptavidin-HRP or the appropriate secondary antibodies were diluted 
1/2000 and incubated for 1 hour at room temperature, and the binding detected using ECL 
chemiluminescence reagent (Pearce, USA) with x-ray film. The results were quantified using 
ImageJ software. 
 
Intestinal Epithelial Cell (IEC) Isolation
IECs from RAG2-/- mice (uninfected or two days after infection with 400L1) were isolated 
using a protocol based on previously described methods (9, 52). A 10-cm piece of jejunum was 
flushed with 10 mL of 37°C Ca2+- and Mg2+-free Hank’s Balanced Salt Solution (CMF-HBSS, 
Gibco, USA). The portal vein was cut to allow an outlet for perfusion fluid. Mice were perfused 
via the left ventricle of the heart with 60 mL of warm CMF-HBSS containing 24 mM EDTA 
(Ambion). The rinsed segment of intestine was immediately removed, inverted, placed in 5 mL 
of ice cold CMF-HBSS, and shaken vigorously for 20 seconds. Cells were allowed to settle on 
ice for 5 minutes, and the supernatant was removed. An aliquot of cells was taken for histology, 
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cold TRIZol reagent was added to the remaining cells, and cells in TRIZol were frozen at -80°C. 
In order to confirm the purity of IECs, the (~30 μL) aliquot of cells for histology was mixed into 
100 μL of melted 3.5% SeaPlaque Agarose (Lonza, USA) dissolved in Dulbecco’s Phosphate 
Buffered Saline (DPBS) and briefly allowed to cool in a 96-well plate. The hardened agarose 
plug was frozen in OCT medium. OCT blocks were stored at -80°C prior to being sectioned with 
a cryostat and stained with Hematoxylin and Eosin.
Microarray
RNA was isolated by chloroform extraction from epithelial cells frozen in TRIZol 
reagent, and concentrated using an RNeasy kit (Qiagen, USA). Prior to hybridization, RNA 
quality was assessed with a BioAnalyzer (Agilent Technologies, USA). RNA integrity numbers 
(RIN) were between 8.4 and 9.6. cDNA synthesis, labeling, hybridization, and microarray 
analysis were performed by the Genomics Core Facility at Cornell University. Generation of 
double-stranded cDNA, preparation and labeling of cRNA, hybridization to GeneChip® Mouse 
Genome 430 2.0 Arrays (Affymetrix, CA), and washing were performed according to the 
standard Affymetrix protocol. 
Data Analysis
 Affymetrix array results were compared between uninfected and infected mice 
(n = 3 mice per group). Data were analyzed through the use of Ingenuity Pathway Analysis 
(Ingenuity® Systems www.ingenuity.com). Canonical pathways analysis identified the pathways 
from the Ingenuity Pathways Analysis library of canonical pathways that were most significant 
to the data set. Molecules from the data set that met the p<0.05 cutoff and were associated with 
a canonical pathway in Ingenuity’s Knowledge Base were considered for the analysis. The 
significance of the association between the data set and the canonical pathway was measured in 2 
ways: 1) A ratio of the number of molecules from the data set that map to the pathway divided by 
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the total number of molecules that map to the canonical pathway is displayed. 2) Fisher’s exact 
test was used to calculate a p-value determining the probability that the association between the 
genes in the dataset and the canonical pathway is explained by chance alone. 
A network/My Pathways is a graphical representation of the molecular relationships 
between molecules. Molecules are represented as nodes, and the biological relationship between 
two nodes is represented as an edge (line). All edges are supported by at least 1 reference from 
the literature, from a textbook, or from canonical information stored in the Ingenuity Pathways 
Knowledge Base. The intensity of the node color indicates the degree of up- (red) or down- 
(green) regulation. Nodes are displayed using various shapes that represent the functional class 
of the gene product.
Statistical Analysis
Experiments were performed twice and data were evaluated using Student’s t test or 
ANOVA with Tukey’s post-hoc test for multiple means. P-values less than 0.05 were considered 
to be statistically significant. All experiments were performed twice, with n = 3 to 8 mice per 
group. Array data were analyzed as described above.
Results
MyD88 is required for efficient amplification of the Th2 cytokine response to infection.
 To investigate a role for TLRs in the innate response to T. spiralis infection, we 
evaluated mice deficient in MyD88, the signaling adaptor for most TLRs. Worm expulsion was 
similar in MyD88-/- mice and littermate controls (Figure 4.1A); however, in MLN cultures from 
MyD88-/- mice the canonical Th2 cytokines IL-4, IL-5, IL-10, and IL-13 were significantly 
diminished, while there was no difference in IFN-g production (Figure 4.1B). Despite these 
differences, there was no difference in the number of eosinophils (Siglec-F+ cells), intestinal 
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Figure 4.1: Role of MyD88 in immunity to T. spiralis. Mice were infected orally with 400 L1. 
(A) Parasite expulsion kinetic in MyD88-/- mice compared to C57Bl/6 littermates. (B) ELISA 
measurement of Th2 cytokines in cAg-restimulated MLN cultures from MyD88-deficient mice 
and C57BL/6 controls. (C) Number of eosinophils (Siglec-F+ cells) in the spleen of infected 
MyD88-/- mice and controls. (D) Serum mmcp-1 concentration and results of mmcp-1 IHC 
staining in sections of the jejunum.
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mastocytosis, or serum mMCP-1 (Figure 4.1C, D). No differences were observed in the parasite 
burden in muscle, and in contrast to the MLN response, the CLN cytokine response to muscle 
infection was not affected by MyD88 deficiency (not shown).
The involvement of MyD88 in amplification of the Th2 response may indicate that TLRs 
are directly activated by parasite products in a way that induces Th2 immunity, that parasite 
destruction of the epithelium leads to TLR activation via endogenous ligands or microbiota, or a 
role for IL-1 family cytokines that utilize this receptor. 
T. spiralis does not directly activate TLRs in vitro or in vivo
To assess the contribution of the microbiota to T. spiralis immunity, we evaluated mice 
that were treated with antibiotics starting one week prior to infection, and continuously during 
infection, using a treatment regimen that was reported to eliminate all culturable bacteria from 
the intestine (20). Antibiotic treatment had no effect on parasite expulsion (Figure 4.2A) or IL-4 
production in MLN cultures, although IL-5 and IL-13 were modestly reduced at a single time 
point (Figure 4.2B). These results are consistent with a modest contribution of the microbiota 
towards inducing the Th2 response to T. spiralis. Although bacteria were easily cleared after 
one week of antibiotic treatment, T. spiralis infection induced an overgrowth of antibiotic-
resistant bacteria (Figure 4.2C). The same infection-induced bacterial overgrowth was observed 
with enrofloxacin (baytril) treatment (not shown). To clarify the results of antibiotic treatment, 
we measured Th2 cytokines in infected TLR2/4-/- mice (Figure 4.3A). These mice had slightly 
accelerated parasite expulsion but no difference in the MLN cytokine response, providing 
additional evidence that intestinal bacteria and their products do not play a significant role in 
amplifying the Th2 response. 
Using a luciferase reporter assay to measure NF-κB activation, we investigated the 
possibility that T. spiralis products directly activate TLRs. HEK293 cells were transfected with 
plasmids encoding human or mouse TLRs, an NF-κB-driven luciferase gene, and a constitutively 
active β-galactosidase gene to control for transfection. Cells were stimulated overnight with T. 
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Figure 4.2: Effect of the microbiota on Th2-mediated immunity. C57Bl/6 mice were treated 
with bacitracin and streptomycin for 7 days, prior to infection with 400 L1. (A) Parasite burden 
in the small intestine of antibiotic treated mice and controls. (B) Cytokine response in cAg-
restimulated MLN cells from antibiotic-treated mice and controls. (C) Quantification of fecal 
bacteria during treatment and infection.
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Figure 4.3: TLR response to T. spiralis in vitro and in vivo (A) Immunity to T. spiralis in 
TLR2/4-/- mice. Mice were infected orally with 400 L1 and parasite expulsion and MLN cytokine 
response were measured 12 days after infection. (B) Activation of mouse and human TLRs by 
T. spiralis crude antigen or the appropriate positive control for each TLR in an HEK293 cell 
luciferase reporter assay. All positive controls were significantly different from the negative 
control (p<0.05 or less). 
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spiralis crude parasite extract, medium control, or the appropriate positive control ligand for 
each TLR. No reporter activity was seen for any of the human or mouse TLRs tested (Figure 
4.3B). We also tested T. spiralis excretory-secretory proteins and the purified phosphorylcholine-
bearing proteins from the parasite with negative results (not shown). Overall, we have found no 
evidence that TLRs promote the Th2 response to T. spiralis.
ST2-/- mice have impaired Th2 immunity
 In the absence of compelling evidence that TLRs induce Th2 immunity to T. 
spiralis, we turned our attention to another receptor that employs MyD88, the IL-33 receptor 
ST2 (35, 55). Similar to MyD88-/- mice, ST2-/- mice displayed normal parasite expulsion but a 
deficient Th2 cytokine response in the MLN (Figures 4.4A, B). The reduction in Th2 cytokines 
was more robust in ST2-/- mice than in MyD88-/- mice, particularly for IL-5 and IL-13. Unlike 
MyD88-/- mice, sera from ST2-/- mice also had significantly lower concentrations of mMCP-1 
(Figure 4C). MyD88-/- and ST2-/- mice also differed during the chronic (muscle) phase of 
infection. ST2-/- mice had normal muscle burdens at 28 dpi (Figure 4.4D), but displayed a 
strongly diminished Th2 cytokine response in CLN cells restimulated with parasite extract 
(Figure 4.4E, F). Despite the decreased Th2 response, histology of the tongue (muscle) during 
infection showed a robust cellular infiltration of the nurse cells (not shown), with numerous 
iNOS+ cells detected, compatible with an enhanced Th1 response (Figure 4.4G). 
IL-33 localization is altered during infection
Transcription of IL-33 was not upregulated in the intestine following infection (Figure 
4.5A); however, the location of IL-33 protein within epithelial cells changed dramatically within 
two days of infection (Figure 4.5B). Prior to infection, IL-33 was diffusely distributed in the 
cytoplasm of IECs, as well as some leukocytes in the lamina propria. Following infection, IL-
33 was concentrated in the nuclei of IECs in the SI. Although IL-33 did not translocate to the 
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Figure 4.4: Infection of ST2-/- mice. (A) Intestinal parasite expulsion kinetics in ST2-/- mice 
compared to C57Bl/6 controls. (B) Cytokine response in parasite antigen-restimulated MLN 
cultures of infected ST2-/- mice and controls. (C) Serum mmcp-1 concentration on day 15 post-
oral infection, measured by ELISA. (D) Muscle burden in ST2-deficient mice and controls at 
28 dpi. (E-F) CLN cytokine response at 17 dpi. (G) iNOS immunohistochemical staining in the 
tongue (muscle) at 17 dpi.
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Figure 4.5: IL-33 mRNA and protein expression during T. spiralis infection. (A) IL-33 
mRNA expression. RNA was isolated from jejunum and ileum of C57Bl/6 mice infected orally 
with 400 L1, and IL-33 was measured using TaqMan qRT-PCR with HPRT as the endogenous 
control. (B) Immunohistochemistry images of intestinal IL-33 staining showing nuclear 
translocation of IL-33 during infection of the SI but not the LI. (C) Quantification of IL-33 
nuclear translocation in C57Bl/6 mice during T. spiralis infection. (D) Quantification of IL-
33 nuclear translocation in Rag2-/- mice and controls. *p<0.05, **p<0.01, ***p<0.001 (versus 
uninfected)
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nucleus during infection of the LI, detection of cytoplasmic IL-33 staining increased in this site 
during infection. The change in the numbers of cells that demonstrated nuclear localization was 
statistically significant in the proximal SI by day 2 and in the distal SI by day 4 (Figure 4.5C), 
consistent with the distal migration of worms during the course of infection (58). Translocation 
occurred in IECs of RAG2-/- mice, confirming the process to be driven by innate, rather than 
adaptive, immune mechanisms (Figure 4.5D). Translocation occurred independently of MyD88 
(not shown). 
IL-33 translocation does not occur in vitro
 We evaluated IL-33 nuclear translocation in an in vitro parasite invasion assay 
using DLD-1 human colon carcinoma cells, which constitutively express IL-33. Monolayers of 
DLD-1 cells were overlaid with T. spiralis parasites in warm agarose, warm agarose alone, or 
no treatment, incubated for 2 hours, and nuclear and cytoplasmic fractions were evaluated for 
IL-33. Although the cellular distributions of monomeric (30 kDa) and dimeric (60 kDa) species 
of IL-33 were not affected by infection (Figure 4.6A, B), both parasite inoculation and warm 
agarose alone contributed to a significant reduction in the amount of dimeric (60 kDa) IL-33 
detected. Failure to induce IL-33 nuclear translocation in this assay suggests that the signal for 
translocation may not be intrinsic to IECs, or that human LI-derived DLD-1 cells behave like 
murine LI IECs in vivo and do not translocate.
Association of IL-33 with NF-κB
 It was recently reported that nuclear IL-33 can bind to NF-κB and suppress 
the activity NF-κB as a transcriptional activator (2). We used immunofluorescent staining 
to visualize the locations of NF-κB and IL-33 in IECs during infection (Figure 4.7). IECs in 
uninfected mice did not show NF-κB staining, and although NF-κB staining increased slightly at 
day 4 of T. spiralis infection, NF- κB remained in the cytoplasm with an apical distribution and 
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Figure 4.6: IL-33 localization in DLD-1 human colon carcinoma cells. DLD-1 cells were 
collected after no treatment (control), warm agarose only, or parasite invasion, and nuclear 
and cytoplasmic fractions were separated. (A) Western blots showing Tubulin-α (cytoplasmic 
marker), Lamin B1 (nuclear marker), and IL-33 content in the nucleus and cytoplasm of the 
cells. (B) Quantitative analysis of the same blots, reported as the ratio of nuclear/cytoplasmic 
signal. 
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Figure 4.7: Location of IL-33 and NF-κB in IECs during infection. Sections of intestine 
from T. spiralis-infected (day 4) and uninfected mice were stained for IL-33 (green) and NF-κB 
(red). Sections of intestine from C57BL/6 mice infected orally with 100 T. gondii (Me49) cysts 
were used as a positive control for NF-κB staining. Iso indicates staining with isotype-matched 
control antibodies for each treatment condition. Slides were analyzed for 3 mice per group and 
representative images are shown. 
Control
T. spiralis
 day 4
T. gondii
 day 4
IL-33 NF-κB Merge Iso (merge)
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did not co-localize with IL-33 in the nuclei of the cells. IECs of mice infected orally with 100 
Toxoplasma gondii (Me49) cysts demonstrated bright NF-κB staining. We concluded that IL-33 
does not sequester nuclear NF-κB in IECs during T. spiralis infection.
Gene expression microarray analysis of IECs
 To further investigate the changes that occur in the intestinal epithelium at a time 
coincident with IL-33 translocation, but prior to the robust inflammatory response, we performed 
genomic microarrays comparing purified IECs from uninfected mice to mice at day 2 pi. To 
reduce the influence of contaminating immune cells, the array samples were collected from 
RAG2-/- mice. Of 26,447 informative (detected) genes, 483 were significantly altered by infection 
(p<0.05). We analyzed the differential genes using Ingenuity Pathways Analysis (IPA). Based on 
the analysis, the ‘top network’ that was altered in the dataset was that of ‘antimicrobial response, 
inflammatory response, and cell death’. The network view of this pathway revealed that many 
genes downstream of NF-κB were downregulated in IECs from infected mice. When the 
expression values from the dataset were overlaid onto the complete NF-κB interaction network, 
we found that 36 genes downstream of NF-κB were significantly diminished during infection 
(Figure 4.8A). In addition, the second ‘top network’ that was altered in the array was that of 
lipid metabolism, which revealed that many genes interacting with TGF-β were influenced by T. 
spiralis infection of IECs. Figure 4.8B shows the overlay of the differentially expressed genes 
onto the TGF-β interaction network. Genes downstream of the stress-responsive transcription 
factor NRF2 were highly induced by infection, as were genes such as Lrg1, Capg, Gsta2, Fdps, 
Ero1l, and hexokinase 1, which carry out pro-survival functions (13, 19, 33, 46, 64, 67). The 
infected and uninfected samples that were compared in the array were collected and processed 
in an identical manner, so it is not likely that the observed increase in NRF2-mediated stress 
response was an artifact of tissue collection. Nine members of the cytochrome p450 family of 
oxidases, mainly in the CYP2 and CYP3 families, were significantly decreased during infection. 
Appendix A lists the genes that were most highly altered in the epithelium during infection.
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Discussion
 We evaluated the mechanisms by which a Th2 response to T. spiralis is induced 
in the intestine and the behavior of IL-33 during infection. Although MyD88-/- mice mounted 
a diminished Th2 response, TLRs did not contribute in an obvious way to this effect. During 
antibiotic treatment, we observed a reproducible outgrowth of antibiotic-resistant bacteria in 
infected mice. Dysbiosis induced by T. spiralis infection has not been described previously, and 
it may occur in mice with normal gut microbiota. Dysbiosis has been implicated in the etiology 
of IBD (10, 60). Gene expression array data confirmed that genes downstream of the TLR-
MyD88 or TLR-TRIF activation pathways were not upregulated in IECs, providing confirmation 
that these mediators are not significant in the epithelial cell response. Mice treated to attain 
complete bacterial clearance, gnotobiotic mice, or mice that cannot sense commensal bacteria 
may prove to have a stronger reduction in Th2 immunity, as we observed a modest effect despite 
achieving only transient bacterial clearance. 
In addition to its role in potentiating TLR signaling, MyD88 also functions in the 
response to IL-33 binding of ST2 (35, 55). The weak production of IL-5 and IL-13 observed 
in ST2-/- mice is consistent with previous reports that IL-33 has a greater influence on IL-5 and 
IL-13, than on IL-4 (8, 37, 55, 56, 70). The defect in Th2 immunity was more pronounced in 
ST2-/- mice than in MyD88-/- mice, as ST2-/- mice had a greater reduction in IL-5 and IL-13 and 
lower serum mMCP-1 concentrations. IL-18 signaling, which is MyD88-dependent, suppresses 
mastocytosis and the Th2 cytokine response to T. spiralis, and the involvement of other IL-1 
family members is not clear (1, 27). Thus, the results observed in MyD88-/- mice may represent 
the conflicting influences of molecules that suppress (e.g., IL-18) and promote (e.g., IL-33) the 
Th2 response. 
Cytokine production by mast cells is an important part of their function during T. spiralis 
infection (30). Our results support the inductive role of mast cells (rather than a direct effector 
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function), because intestinal expulsion was not delayed in ST2-/- mice despite a diminished 
mMCP-1 response. Similarly, mice fully deficient in mMCP-1 have only a moderately delayed 
expulsion (34).  Taken together with our results, these observations suggest that there is a 
threshold level of mMCP-1 that is sufficient to promote parasite clearance from the intestine. 
Th2 immunity to chronic (muscle) infection with T. spiralis was strongly dependent 
on ST2, although there was no difference in muscle burden in ST2-/- mice. We have previously 
shown that a Th1 response is protective against the muscle phase of infection (24). Eosinophils 
execute a novel function during chronic T. spiralis infection, in which they promote survival of 
the parasite, rather than protection from it (24). In the absence of eosinophils, muscle larvae are 
killed by NO (24). It has been shown in other models that eosinophils express ST2 (17, 57). Our 
results suggest that the role of eosinophils in protecting the parasite during chronic infection is 
likely to be independent of ST2, as iNOS production in ST2-/- mice did not correlate with parasite 
killing. 
We observed constitutive expression of IL-33 in mouse small and large intestines, mainly 
localized to IECs and lamina propria leukocytes. In contrast to Trichuris muris infection, IL-
33 mRNA expression did not increase during infection (29); however, following epithelial cell 
invasion by the parasite, IL-33 became concentrated in the nuclei of IECs. A similar cellular 
distribution of IL-33 has been observed in the human intestine: IL-33 is present at a low level 
in the cytoplasm of IECs in healthy individuals, and is concentrated in the nucleus during 
ulcerative colitis (7). Further studies are warranted to shed light on the nuclear functions of 
IL-33 in the intestine, and whether nuclear IL-33 contributes to a defensive response in the 
mucosa. Translocation was not dependent on the adaptive immune response. It did not occur in 
the mouse large intestine or in human DLD-1 colon carcinoma cells, indicating that differences 
in the behavior of IL-33 during infection with T. muris and T. spiralis may relate to the different 
habitats of these parasites. T. muris colonizes the cecum, while T. spiralis predominantly inhabits 
the SI. Factors intrinsic to the SI may be required to transmit the signal that induces IL-33 
translocation. Translocation was often observed along the length of an entire villus, although 
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the parasite is mainly found at the crypt-villus junction. Myofibroblasts along the basement 
membrane transmit information between disparate locations in the epithelium, making this cell 
type a likely candidate for disseminating the signal that induces translocation.
In the endothelia of certain tissues, IL-33 is constitutively located in the nucleus, where 
it binds to the histone H2A/H2B acidic pocket, and is released in response to inflammatory 
stimuli (36, 53). In vitro, nuclear translocation was associated with reduced expression of a 
Gal4 reporter gene, and was proposed as a mechanism for controlling proliferation in pancreatic 
stellate cells (16, 40). In addition, it was recently reported that nuclear IL-33 binds to NF-κB 
and prevents it from acting as a transcriptional activator in transfected cells (2). Although our 
analysis of gene expression in IECs revealed that targets downstream of NF-κB were diminished 
at 2 days post-infection, we did not observe colocalization of NF-κB with IL-33 in the nuclei of 
IECs.  Suppression of NF- κB may occur due to an IL-33-independent mechanism, an indirect 
interaction between IL-33 and NF-κB, or by IL-33 binding to NF-κB in the cytoplasm of the 
cells. In other models, activation of TLRs causes an increase in expression of genes activated by 
NF- κB, so our array findings highlight the suppression (or lack of activation) of TLRs in this 
system. 
In order to limit the comparison to genes directly altered in the epithelium, expression 
array analysis was performed using purified IECs from RAG2-/- mice collected at 2 dpi. This 
design eliminated lymphocytes and avoided the enteropathy initiated by NK cell-derived IL-13 
that occurs in immunodeficient mice (41). 
In addition to revealing the absence of NF- κB activation, other changes in gene 
expression were evident at a time when IL-33 is present in the nucleus. Genes downstream of the 
stress-responsive transcription factor NRF2 were highly induced by infection. Upregulation of 
pro-survival genes and downregulation of the cytochrome p450 oxidase family indicate that the 
epithelium becomes altered in a way that allows it to combat oxidative stress while maintaining 
the function of the mucosal barrier. IPA analysis revealed that lipid metabolism pathways were 
altered during infection, particularly molecules in the TGF-β network. Proteins that promote the 
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response to TGF-β, such as MIF, ATF-2 and several TGF-β receptors, were strongly upregulated, 
while the negative regulators SMAD6 and SMAD7 were decreased during infection. These 
changes suggest that the sensitivity to TGF-β is increased in the epithelium during infection.
Overall, our findings suggest that a rapid response is induced in the intestinal epithelium, 
characterized by the suppression of NF-κB activation, induction of a pro-survival program, and 
an increase in the sensitivity to TGF-β. These changes occur at a time coincident with IL-33 
nuclear translocation, and are independent of the adaptive immune response. In the absence of 
such changes, dysbiosis induced by infection could lead to the production of TNF-a via NF- 
κB, promoting a non-protective and destructive Th1 response. Epithelial cell death (rather than 
survival) would allow the microbiota access into the lamina propria, which would also likely 
contribute to pathology, rather than protective immunity. In contrast, TGF- β helps regulate 
inflammation and protects the epithelial barrier. Even in the absence of an adaptive immune 
response, innate mediators in the epithelium respond to infection in a manner appropriate for a 
physically destructive intestinal pathogen. Furthermore, release of the endogenous danger signal 
IL-33 provides an innate mechanism for recognizing epithelial damage, and leads to robust 
induction of the Th2 response.
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Chapter 5
Summary and Conclusions
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Intestinal helminths infect over 2 billion people worldwide, and the mechanisms by 
which immunity to these pathogens is induced remain poorly understood (27). We investigated 
the role of mast cells in protective secondary immunity, differences in protection and pathology 
between different regions of the intestine, and the contribution of innate mediators in initiating 
the Th2 response to infection.  Secondary immunity to Trichinella spiralis involves a novel 
immune mechanism, in which the systemic antibody response is crucial to the expression of 
intestinal immunity (2). In rats, 90% of parasites are cleared from the intestine within one hour 
of a challenge infection. Understanding this mechanism may aid in the development of vaccines, 
which often aim to deliver antigen systemically in order to protect a mucosal surface. 
Although tyvelose-specific antibodies are sufficient to confer protection on suckling 
rats, adult rats require an additional inflammatory mediator, such as adoptive transfer of T 
cells or a heterologous infection (2, 4, 6). We showed that intestinal priming is not the factor 
required to enable antibody-mediated protection in adult rats, as infection limited to the muscle 
phase induces protective immunity. In addition, our results contradict the dogma that mast 
cell degranulation directly contributes to the mechanism of parasite expulsion. However, mast 
cell deficient rats have compromised expulsion, and mast cell-derived cytokines contribute 
to protective immunity in mice during primary infection (16, 25). We also hypothesized that 
peritoneal mast cells constitute the link between systemic and intestinal sites of infection, but 
transfer of these cells, in combination with antibody, did not confer protection (not shown). 
Taken together these facts suggest that the crucial function of mast cells during rapid expulsion 
may be during the initiation of immunity, rather than the effector phase. 
Immunity to T. spiralis is often compared with immunity to Trichuris muris, a cecal 
dwelling nematode. Although the two parasites are closely related, the mechanisms of worm 
clearance are distinct, with mast cells reported to play a prominent role in expulsion of adult T. 
spiralis, while epithelial cell turnover and function appear to be key to the clearance of T. muris 
(5, 14). The differences in effector mechanisms may be dictated by properties intrinsic to each 
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parasite, or by their preferred locations in the intestinal tract. Similarly, differences between two 
common types of inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, may 
be caused by mechanisms intrinsic to the etiology of each disease state or to differences in the 
affected sites. 
During intestinal colonization and expulsion, T. spiralis ultimately passes through every 
region of the rodent intestine, and these sites vary greatly with regard to morphology, physiology, 
and immunology. We observed differences in the quality of the Th2 cytokine response between 
the small and large intestines (SI and LI, Chapter 3). In addition, a potent mastocytosis occurs 
in the SI, but was not present in the LI. Enteropathy in the LI was tightly regulated by IL-10, 
while infection-induced pathology occurred in the SI even in the presence of IL-10. However, 
IL-10-deficient mice produced significantly more IL-17 in the SI than C57BL/6 controls, and 
IL-17 production correlated with an increase in neutrophil infiltration. Our results demonstrate 
that mucosal mastocytosis and the cytokines that influence it are not prominent in the LI during 
worm expulsion, and that immunopathology is more tightly regulated in the LI than the SI. Thus, 
the mechanisms of immunity and enteropathy vary in different regions of the intestine during 
helminth infection. The results presented in this chapter support the hypothesis that infection of 
distinct regions of the intestine contributes to differences between the mechanisms of immunity 
to T. spiralis and Trichuris muris. Further work should utilize intra-cecal injection of parasites, to 
discern if infections limited to the LI can promote SI immunity. Evaluation and adoptive transfer 
of CCR9+ lymphocytes isolated from the SI would further clarify the presence of a pathogenic 
IL-17-producing population, and whether these cells can home to the SI or LI after transfer. 
We went on to investigate the influence of innate mediators in inducing the Th2 response 
to infection. We collected evidence suggesting that MyD88 is influential in promoting Th2 
responses (Chapter 4). To further dissect the role of MyD88, we showed that mice treated to alter 
the gut microbiota had a modest decrease in Th2 cytokine production. However, TLR2/4-/- mice 
did not recapitulate this reduction, and we did not observe activation of TLRs by T. spiralis 
products in vitro. Dampened immunity in MyD88-/- mice did not correspond with impaired 
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parasite expulsion. Although mice completely deficient in Th2 cytokines have impaired parasite 
clearance, it is possible that a threshold level of IL-4 is sufficient to promote expulsion (22). In 
some cases, the mechanism of TLR-dependent modulation of the immune response by helminth-
derived molecules is to dampen the response of TLRs to Th1-driving ligands, such as LPS (9, 
12, 13, 26). Thus, although a more complex mechanism may be at play between T. spiralis, 
TLRs, and non-parasite TLR stimuli (i.e., microbiota), our results do not support a role for 
direct activation of TLRs by parasite-derived molecules in the MyD88-dependent induction of 
Th2 immunity. Stimulation of TLRs (other than TLR2/4) by endogenous DAMPs released from 
necrotic cells, such as host nucleic acids, remains a possible mechanism of immune induction 
during T. spiralis infection.
In addition to its role in TLR signaling, MyD88 also perpetuates the response to IL-1 
family members, including IL-18 and IL-33 (1, 17, 19). IL-18 is known to inhibit the Th2 
response during T. spiralis infection, but the influence of other IL-1 family members has not been 
reported. We investigated the importance of ST2, the receptor for IL-33. ST2-/- mice displayed a 
strong reduction in the Th2 cytokine response, particularly for IL-5 and IL-13. These results fit 
with previous studies that have shown that IL-33 has a stronger influence in inducing IL-5 and 
IL-13, relative to IL-4 (8, 18, 23, 24, 28). Although many papers cite the importance of IL-33 in 
helminth infection, the previous report (during T. muris infection) only encompassed the effects 
of administering recombinant IL-33 (15). Use of a mouse strain with targeted deletion of ST2 
allows for a stronger evaluation of the role of IL-33 during helminth infection. 
In addition to its role as a paracrine cytokine, IL-33 also carries out an intracellular 
signaling mechanism, which is not well-understood (11). We found that IL-33 is constitutively 
expressed in intestinal tissue, and is not upregulated during infection. IL-33 was observed in 
intestinal leukocytes and in epithelial cells, where it concentrated in the nucleus within two days 
of infection. The behavior of IL-33 that we observed in mice follows a similar pattern to what 
has recently been reported for humans: IL-33 was present at a low level in the cytoplasm of IECs 
in healthy controls, and became concentrated in the nucleus during ulcerative colitis (7). Given 
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this parallel, and the necessity for a better understanding of the behavior of the immune system 
during IBD, further study is warranted to clarify the function of IL-33 nuclear translocation 
during Th2-mediated intestinal inflammation. In addition, elucidation of the mediators that 
trigger translocation may provide a useful clinical target for reducing inflammation and 
promoting epithelial healing during IBD.
In addition to binding histones, nuclear IL-33 binds to NF-κB and prevents it from 
acting as a transcriptional activator (3, 21). We observed that targets downstream of NF-κB were 
diminished in infected epithelial cells. However, immunofluorescent staining did not reveal 
nuclear NF- κB in cells with nuclear IL-33. Downregulation of NF- κB targets may occur due 
to an IL-33-independent mechanism, an indirect interaction between IL-33 and NF-κB, or by 
IL-33 binding to NF-κB in the cytoplasm of the cells. Our results highlight the importance of 
evaluating the behavior of IL-33 in vivo, as we did not see the same pattern that was reported in a 
transfected cell line in vitro. 
Suppression of epithelial NF- κB activation during T. spiralis infection differs from what 
has been observed in other models of intestinal infection: NF-κB DNA binding activity in the 
epithelium is induced by T. muris infection, and mice with epithelial-specific inhibition of NF-κB 
have a Th1 response, which is pathologic, rather than protective (29). Similarly, infection with 
Salmonella enterica induces NF-κB activation in IECs (10). However, the specific habitats of 
these pathogens differ from that of T. spiralis. T. muris lives imbedded in the epithelium of the 
cecum, and remains within a limited tunnel of dead cells (reviewed in (20)). Salmonella invades 
epithelial cells of the distal ileum and LI, without causing these cells to undergo necrosis, and 
ultimately infects macrophages in the lamina propria (reviewed in (30)). These differences 
are consistent with the hypothesis that physical disruption of the epithelium during T. spiralis 
infection contributes to the suppression of NF-κB in our model. In addition, we observed 
differences in the behavior of IL-33 between the SI and LI, which may correlate with the 
differences in behavior of NF- κB between T. muris and T. spiralis.
Four hundred and eighty-three genes were differentially regulated in our genomic 
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microarray. Rather than subjectively choosing genes of interest, we used Ingenuity Pathways 
Analysis (IPA) to identify pathways that are strongly altered in intestinal epithelial cells (IECs) 
during infection. This type of analysis provides an objectively ranked list of the most highly 
altered pathways, as well as the ability to identify pathways in which many genes undergo a 
low level of regulation. In addition to revealing diminished NF- κB activation, we observed 
other global changes in infected IECs, at a time when IL-33 is present in the nucleus. Genes 
downstream of the stress-responsive transcription factor NRF2 were highly induced by infection. 
NRF2 responds to oxidative stress by activating the transcription of antioxidant enzymes. 
NRF2 signaling has been widely studied, and it would be of interest to measure the behavior 
of molecules in this pathway during epithelial invasion in vitro. The infected and uninfected 
samples that were compared in the array were collected and processed in an identical manner, 
so it is not likely that the observed increase in NRF2-mediated stress response was an artifact of 
tissue collection.
IPA analysis also revealed that lipid metabolism pathways were altered during infection, 
particularly molecules in the TGF-β network. Proteins that promote the response to TGF-β, 
such as MIF, ATF-2 and several TGF-β receptors, were strongly upregulated, while the negative 
regulators SMAD6 and SMAD7 were decreased during infection. Overall, the results suggest 
that a global response is induced in the epithelium, which leads to a reduction in the NF-κB-
mediated pathologic response, protection of the mucosal barrier by TGF-β, and the induction of a 
pro-survival program. These changes occur at a time coincident with IL-33 nuclear translocation, 
and prior to initiation of the adaptive response. Further work is needed to determine if nuclear 
IL-33 is required for the induction of protective changes in the epithelium during infection. Our 
results support a model in which TLR-independent activation by the microbiota, in combination 
with epithelial tissue damage and release of IL-33 (by IECs or leukocytes) promote Th2 
immunity during T. spiralis infection.
 Taken together, these three studies clarify the interactions by which a potent Th2 
response to T. spiralis is induced. We reported that mast cells are likely to play an inductive, 
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rather than effector, role in protective immunity; that the regulation and mechanisms of 
inflammation induced by a single parasite differ between distinct intestinal locations within the 
host; that innate mediators such as IL-33 contribute to the adaptive response; and that nuclear 
translocation of IL-33 coincides with dramatic changes that occur in the epithelium within two 
days of infection. These results allow us to conclude that a complex interaction between innate 
mediators and adaptive immunity is required for both protective and pathologic responses.
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Appendix A
Most highly altered genes in the murine epithelium during T. spiralis infection
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